{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## **Published research on promising Drugs**\n",
    "\n",
    "This work search for recent research on drugs that shows improvement in human health against the current pandemic. It uses keywords and trial. The new keywords, drug names and concepts are published - slowly putting together a picture of drugs that may show promise for help fighting this pandemic. \n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: rake-nltk in /opt/conda/lib/python3.7/site-packages (1.0.4)\n",
      "Requirement already satisfied: nltk in /opt/conda/lib/python3.7/site-packages (from rake-nltk) (3.5)\n",
      "Requirement already satisfied: click in /opt/conda/lib/python3.7/site-packages (from nltk->rake-nltk) (7.1.1)\n",
      "Requirement already satisfied: tqdm in /opt/conda/lib/python3.7/site-packages (from nltk->rake-nltk) (4.45.0)\n",
      "Requirement already satisfied: regex in /opt/conda/lib/python3.7/site-packages (from nltk->rake-nltk) (2020.4.4)\n",
      "Requirement already satisfied: joblib in /opt/conda/lib/python3.7/site-packages (from nltk->rake-nltk) (0.14.1)\n"
     ]
    }
   ],
   "source": [
    "import spacy\n",
    "import numpy as np\n",
    "import pandas as pd\n",
    "import re\n",
    "import os\n",
    "import json\n",
    "from pprint import pprint\n",
    "from copy import deepcopy\n",
    "import math\n",
    "import torch\n",
    "!pip install rake-nltk\n",
    "from rake_nltk import Rake\n",
    "from nltk.corpus import stopwords\n",
    "from rake_nltk import Metric, Rake"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "python packages imported\n",
      "total documents  (57366, 8)\n",
      "COVID-19 focused documents  (5615, 8)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sha</th>\n",
       "      <th>title</th>\n",
       "      <th>doi</th>\n",
       "      <th>abstract</th>\n",
       "      <th>publish_time</th>\n",
       "      <th>authors</th>\n",
       "      <th>journal</th>\n",
       "      <th>full_text_file</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>12519</th>\n",
       "      <td>b5d303cbcfe6be92d733ec593118b388db77452e</td>\n",
       "      <td>Complete Genome Sequence of a 2019 Novel Coron...</td>\n",
       "      <td>10.1128/mra.00169-20</td>\n",
       "      <td>a complete genome sequence was obtained for a ...</td>\n",
       "      <td>2020-03-12</td>\n",
       "      <td>Sah, Ranjit; Rodriguez-Morales, Alfonso J.; Jh...</td>\n",
       "      <td>Microbiol Resour Announc</td>\n",
       "      <td>comm_use_subset</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12520</th>\n",
       "      <td>ce358c18aac69fc83c7b2e9a7dca4a43b0f60e2e</td>\n",
       "      <td>First cases of coronavirus disease 2019 (COVID...</td>\n",
       "      <td>10.2807/1560-7917.es.2020.25.9.2000178</td>\n",
       "      <td>in the who european region, covid-19 surveilla...</td>\n",
       "      <td>2020-03-05</td>\n",
       "      <td>Spiteri, Gianfranco; Fielding, James; Diercke,...</td>\n",
       "      <td>Euro Surveill</td>\n",
       "      <td>comm_use_subset</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12525</th>\n",
       "      <td>a1f9e6d1c2717f4555275f25d6169063b7f8bb23</td>\n",
       "      <td>What further should be done to control COVID-1...</td>\n",
       "      <td>10.1186/s12916-020-01551-8</td>\n",
       "      <td>no data providedwhat further should be done to...</td>\n",
       "      <td>2020-03-13</td>\n",
       "      <td>He, Zhenjian</td>\n",
       "      <td>BMC Med</td>\n",
       "      <td>comm_use_subset</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12536</th>\n",
       "      <td>no data provided</td>\n",
       "      <td>Is A Problem Shared, A Problem Halved? Not Alw...</td>\n",
       "      <td>10.5005/jp-journals-10071-23365</td>\n",
       "      <td>how to cite this article: bhosale s, kulkarni ...</td>\n",
       "      <td>2020-02-23</td>\n",
       "      <td>Bhosale, Shilpushp; Kulkarni, Atul P</td>\n",
       "      <td>Indian J Crit Care Med</td>\n",
       "      <td>no data provided</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12537</th>\n",
       "      <td>4b29b65801480de25dd4b503bfd7939a1884b97e</td>\n",
       "      <td>The Effects of Social Support on Sleep Quality...</td>\n",
       "      <td>10.12659/msm.923549</td>\n",
       "      <td>background: coronavirus disease 2019 (covid-19...</td>\n",
       "      <td>2020-03-05</td>\n",
       "      <td>Xiao, Han; Zhang, Yan; Kong, Desheng; Li, Shiy...</td>\n",
       "      <td>Med Sci Monit</td>\n",
       "      <td>noncomm_use_subset</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                            sha  \\\n",
       "12519  b5d303cbcfe6be92d733ec593118b388db77452e   \n",
       "12520  ce358c18aac69fc83c7b2e9a7dca4a43b0f60e2e   \n",
       "12525  a1f9e6d1c2717f4555275f25d6169063b7f8bb23   \n",
       "12536                          no data provided   \n",
       "12537  4b29b65801480de25dd4b503bfd7939a1884b97e   \n",
       "\n",
       "                                                   title  \\\n",
       "12519  Complete Genome Sequence of a 2019 Novel Coron...   \n",
       "12520  First cases of coronavirus disease 2019 (COVID...   \n",
       "12525  What further should be done to control COVID-1...   \n",
       "12536  Is A Problem Shared, A Problem Halved? Not Alw...   \n",
       "12537  The Effects of Social Support on Sleep Quality...   \n",
       "\n",
       "                                          doi  \\\n",
       "12519                    10.1128/mra.00169-20   \n",
       "12520  10.2807/1560-7917.es.2020.25.9.2000178   \n",
       "12525              10.1186/s12916-020-01551-8   \n",
       "12536         10.5005/jp-journals-10071-23365   \n",
       "12537                     10.12659/msm.923549   \n",
       "\n",
       "                                                abstract publish_time  \\\n",
       "12519  a complete genome sequence was obtained for a ...   2020-03-12   \n",
       "12520  in the who european region, covid-19 surveilla...   2020-03-05   \n",
       "12525  no data providedwhat further should be done to...   2020-03-13   \n",
       "12536  how to cite this article: bhosale s, kulkarni ...   2020-02-23   \n",
       "12537  background: coronavirus disease 2019 (covid-19...   2020-03-05   \n",
       "\n",
       "                                                 authors  \\\n",
       "12519  Sah, Ranjit; Rodriguez-Morales, Alfonso J.; Jh...   \n",
       "12520  Spiteri, Gianfranco; Fielding, James; Diercke,...   \n",
       "12525                                       He, Zhenjian   \n",
       "12536               Bhosale, Shilpushp; Kulkarni, Atul P   \n",
       "12537  Xiao, Han; Zhang, Yan; Kong, Desheng; Li, Shiy...   \n",
       "\n",
       "                        journal      full_text_file  \n",
       "12519  Microbiol Resour Announc     comm_use_subset  \n",
       "12520             Euro Surveill     comm_use_subset  \n",
       "12525                   BMC Med     comm_use_subset  \n",
       "12536    Indian J Crit Care Med    no data provided  \n",
       "12537             Med Sci Monit  noncomm_use_subset  "
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "print ('python packages imported')\n",
    "\n",
    "from IPython.core.display import display, HTML\n",
    "\n",
    "def search_focus(df):\n",
    "    dfa = df[df['abstract'].str.contains('covid')]\n",
    "    dfb = df[df['abstract'].str.contains('-cov-2')]\n",
    "    dfc = df[df['abstract'].str.contains('cov2')]\n",
    "    dfd = df[df['abstract'].str.contains('ncov')]\n",
    "    frames=[dfa,dfb,dfc,dfd]\n",
    "    df = pd.concat(frames)\n",
    "    df=df.drop_duplicates(subset='title', keep=\"first\")\n",
    "    return df\n",
    "\n",
    "# load the meta data from the CSV file using 3 columns (abstract, title, authors),\n",
    "df=pd.read_csv('metadata.csv', usecols=['title','journal','abstract','authors','doi','publish_time','sha','full_text_file'])\n",
    "print ('total documents ',df.shape)\n",
    "#drop duplicates\n",
    "#df=df.drop_duplicates()\n",
    "#drop NANs \n",
    "df=df.fillna('no data provided')\n",
    "df = df.drop_duplicates(subset='title', keep=\"first\")\n",
    "# convert abstracts to lowercase\n",
    "df[\"abstract\"] = df[\"abstract\"].str.lower()+df[\"title\"].str.lower()\n",
    "#show 5 lines of the new dataframe\n",
    "df=search_focus(df)\n",
    "df = df[df['publish_time'].str.contains('2020')]\n",
    "print ('COVID-19 focused documents ',df.shape)\n",
    "df.head()\n",
    "\n",
    "# add full text back after testing"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "focus term:  drug\n",
      "# focused papers (4896, 8)\n"
     ]
    }
   ],
   "source": [
    "import functools\n",
    "def search_focus_shape(df,focus):\n",
    "    df1=df[functools.reduce(lambda a, b: a&b, (df['abstract'].str.contains(s) for s in focus))]\n",
    "    return df1\n",
    "\n",
    "focus_term='drug'\n",
    "df1=search_focus_shape(df,focus_term)\n",
    "print ('focus term: ',focus_term)\n",
    "print ('# focused papers',df1.shape)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['19 drug', '2 logs', '3 ).', '3d number', 'administered drug', 'anticytokine drug', 'antimalarial drug', 'antitumor drug', 'antiviral drug', 'antivirus drug', 'approved drug', 'arb drug', 'available drug', 'candidate drug', 'clinical drug', 'cmt drug', 'data provideddrug', 'designed drug', 'driven drug', 'drug ),', 'drug azt', 'drug center', 'drug detection', 'drug drug', 'drug effects', 'drug labeling', 'drug therapy', 'drug type', 'drug use', 'drug used', 'drug week', 'effective drug', 'efficacious drug', 'existing drug', 'find drug', 'flu drug', 'gold drug', 'hcv drug', 'hiv drug', 'including drug', 'induced attention', 'inhalable drug', 'inhibitory drug', 'narcotic drug', 'new drug', 'novel drug', 'potential drug', 'promising drug', 'proven drug', 'purchasable drug', 'repurposed drug', 'several drug', 'specific drug', 'structural drug', 'therapeutic drug', 'three drug', 'treat anti', 'treat resource', 'treat target', 'unlicensed drug', 'us food', 'viral drug', 'virus drug']\n",
      "___________________\n"
     ]
    }
   ],
   "source": [
    "r = Rake(ranking_metric=Metric.DEGREE_TO_FREQUENCY_RATIO,min_length=2, max_length=2) # Uses stopwords for english from NLTK, and all puntuation characters.Please note that \"hello\" is not included in the list of stopwords.\n",
    "\n",
    "def extract_data(text,word):\n",
    "    extract=''\n",
    "    if word in text:\n",
    "        #text = re.sub(r'[^\\w\\s]','',text)\n",
    "        res = [i.start() for i in re.finditer(word, text)]\n",
    "        after=text[res[0]:res[0]+15]\n",
    "        before=text[res[0]-15:res[0]]\n",
    "        raw = before+after\n",
    "        parts=raw.split()\n",
    "        parts = parts[1:-1]\n",
    "        extract= ' '.join(parts)\n",
    "        extract=extract.replace('drugs','drug')\n",
    "    return extract\n",
    "text=''\n",
    "for index, row in df1.iterrows():\n",
    "    extracted=extract_data(row['abstract'],focus_term)\n",
    "    if extracted!='':\n",
    "        text=text+' '+extracted\n",
    "a=r.extract_keywords_from_text(text)\n",
    "term_list=r.get_ranked_phrases()\n",
    "term_list = sorted(term_list, key=str.lower)\n",
    "#c=r.get_ranked_phrases_with_scores()\n",
    "print(term_list)\n",
    "#print(c)\n",
    "print('___________________')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "administered drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-03-30</td>\n",
       "      <td>Medical treatment of 55 patients with COVID-19 from seven cities in northeast China who fully recovered: a single-center, retrospective, observational study</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.28.20045955</td>\n",
       "      <td>administered drugs and intervention times were compared in 47 and eight patients with mild and severe symptoms, respectively 0.08</td>\n",
       "      <td>0.077778</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "anticytokine drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-04</td>\n",
       "      <td>Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy</td>\n",
       "      <td>https://doi.org/10.1016/j.ekir.2020.04.001</td>\n",
       "      <td>in the second inflammatory phase of the disease, immunosuppressive strategies (for example with glucocorticoids or anticytokine drugs) may be considered 0.08</td>\n",
       "      <td>0.075</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "antimalarial drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-05-31</td>\n",
       "      <td>Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy</td>\n",
       "      <td>https://doi.org/10.1016/j.jaut.2020.102442</td>\n",
       "      <td>antimalarial drugs, commonly used in rheumatology, may alter the lysosomal proteases that mediates the viral entry into the cell and have demonstrated efficacy in improving the infection 0.07</td>\n",
       "      <td>0.068519</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-05-31</td>\n",
       "      <td>Of chloroquine and COVID-19</td>\n",
       "      <td>https://doi.org/10.1016/j.antiviral.2020.104762</td>\n",
       "      <td>abstract recent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (sars-cov-2) 0.07</td>\n",
       "      <td>0.067241</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-17</td>\n",
       "      <td>Chloroquine paradox may cause more damage than help fight COVID-19</td>\n",
       "      <td>https://doi.org/10.1016/j.micinf.2020.04.004</td>\n",
       "      <td>antimalarial drug chloroquine (chl) and its safer derivative hydroxychloroquine (hchl) have been proposed to be repurposed to treat sars coronavirus-2 (sars-cov-2), the causative agent of covid-19 0.18</td>\n",
       "      <td>0.176923</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-14</td>\n",
       "      <td>Neuropsychiatric adverse events of chloroquine: A real-world pharmacovigilance study using the FAERS database</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.10.20061358</td>\n",
       "      <td>objectives: in early april 2020, the antimalarial drug, chloroquine, has been approved as an emergency treatment for the coronavirus disease 2019 (covid-19) in the united states and in europe 0.07</td>\n",
       "      <td>0.067241</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-05</td>\n",
       "      <td>Clinical trial analysis of 2019-nCoV therapy registered in China</td>\n",
       "      <td>https://doi.org/10.1002/jmv.25733</td>\n",
       "      <td>with more and more patients diagnosed, china has carried out more than one hundred clinical studies of new coronavirus infection, including antiviral drugs, antimalarial drugs, glucocorticoids, plasma therapy, virus vaccine and other western drugs, while chinese medicine researches accounted for half of studies 0.06</td>\n",
       "      <td>0.061628</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "antitumor drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-09</td>\n",
       "      <td>Vulnerabilities of the SARS-CoV-2 virus to proteotoxicity – opportunity for repurposed chemotherapy of COVID-19 infection</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.07.029488</td>\n",
       "      <td>we found antitumor drugs, doxorubicin and paclitaxel, increase cellular methylglyoxal to virucidal levels 0.09</td>\n",
       "      <td>0.088462</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020</td>\n",
       "      <td>Expert recommendations on the management of patients with advanced non-small cell lung cancer during epidemic of COVID-19 (Trial version)</td>\n",
       "      <td>https://doi.org/10.3760/cma.j.cn112147-20200221-00138</td>\n",
       "      <td>during epidemic of covid-19, a guideline for the optimal management of patients with advanced lung cancer urgently needs to be proposed to distinguish the symptoms of covid-19 and the side effects of antitumor drugs 0.06</td>\n",
       "      <td>0.064706</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "antiviral drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-06-30</td>\n",
       "      <td>Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses</td>\n",
       "      <td>https://doi.org/10.1016/j.onehlt.2020.100128</td>\n",
       "      <td>remdesivir (gs-5734™) is a broad-spectrum antiviral drug that is now being tested as a potential treatment for covid-19 in international, multi-site clinical trials 0.19</td>\n",
       "      <td>0.186957</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-05-31</td>\n",
       "      <td>Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy</td>\n",
       "      <td>https://doi.org/10.1016/j.jaut.2020.102442</td>\n",
       "      <td>the management includes ventilatory support and broad-spectrum antiviral drugs, empirically utilized, as a targeted therapy and vaccines have not been developed 0.07</td>\n",
       "      <td>0.073810</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-22</td>\n",
       "      <td>COVID-19: Disease, management, treatment, and social impact</td>\n",
       "      <td>https://doi.org/10.1016/j.scitotenv.2020.138861</td>\n",
       "      <td>it was analyzed that a combination of antiviral drugs with hydroxyl-chloroquine and azithromycin (with the consultation of a medical practitioner) may be the best option to treat the patients, depending on the patient's conditions and symptoms 0.06</td>\n",
       "      <td>0.063889</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-22</td>\n",
       "      <td>COVID-19 outbreak: Migration, effects on society, global environment and prevention</td>\n",
       "      <td>https://doi.org/10.1016/j.scitotenv.2020.138882</td>\n",
       "      <td>till now there is no report of any clinically approved antiviral drugs or vaccines that are effective against covid-19 0.08</td>\n",
       "      <td>0.076316</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-22</td>\n",
       "      <td>Impact of Social Distancing Measures on COVID-19 Healthcare Demand in Central Texas</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.16.20068403</td>\n",
       "      <td>in the absence of effective antiviral drugs and vaccines, well-targeted social distancing measures are essential for mitigating the covid-19 pandemic, reducing strain on local health systems, and preventing mortality 0.07</td>\n",
       "      <td>0.067241</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-21</td>\n",
       "      <td>Elucidating the differences in the molecular mechanism of receptor binding between 2019-nCoV and the SARS-CoV viruses using computational tools</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.21.053009</td>\n",
       "      <td>many biotechnology laboratories are rushing to develop therapeutic antibodies and antiviral drugs for treatment of this viral disease 0.08</td>\n",
       "      <td>0.077778</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-21</td>\n",
       "      <td>Human iPSC-Derived Cardiomyocytes are Susceptible to SARS-CoV-2 Infection</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.21.051912</td>\n",
       "      <td>these studies show that sars-cov-2 can infect hipsc-cms in vitro, establishing a model for elucidating the mechanisms of infection and potentially a cardiac-specific antiviral drug screening platform 0.17</td>\n",
       "      <td>0.174074</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-19</td>\n",
       "      <td>Déjà vu: Stimulating open drug discovery for SARS-CoV-2</td>\n",
       "      <td>https://doi.org/10.1016/j.drudis.2020.03.019</td>\n",
       "      <td>here, we propose, based on open antiviral drug discovery approaches for previous outbreaks, that there could still be gaps in our approach to drug discovery 0.22</td>\n",
       "      <td>0.220000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-19</td>\n",
       "      <td>Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status</td>\n",
       "      <td>https://doi.org/10.1016/j.meegid.2020.104327</td>\n",
       "      <td>favilavir is an antiviral drug that is approved in japan for common influenza treatment and is now approved to treat symptoms of covid-19 in china 0.18</td>\n",
       "      <td>0.180000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-15</td>\n",
       "      <td>Epidemiological investigation and intergenerational clinical characteristics of 24 COVID-19 patients associated with supermarket cluster</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.11.20058891</td>\n",
       "      <td>treatment: antiviral drug (100%), chinese medicine (100%), common oxygen therapy (45 0.28</td>\n",
       "      <td>0.281818</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-15</td>\n",
       "      <td>TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.15.042085</td>\n",
       "      <td>currently, there is no approved antiviral drug for treating covid-19 patients and there is an urgent need for specific antiviral therapies and vaccines 0.23</td>\n",
       "      <td>0.230435</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-14</td>\n",
       "      <td>Efficacy of remdesivir versus placebo for the treatment of COVID-19: A protocol for systematic review and meta-analysis of randomized controlled trials</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.09.20059196</td>\n",
       "      <td>remdesivir, a nucleotide-analogue antiviral drug developed for ebola, is determined to prevent and stop infections with covid-19, while results are yet controversial 0.19</td>\n",
       "      <td>0.190909</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-14</td>\n",
       "      <td>Discovery of baicalin and baicalein as novel, natural product inhibitors of SARS-CoV-2 3CL protease in vitro</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.13.038687</td>\n",
       "      <td>the 3c-like protease (3clpro), a highly conserved protease indispensable for replication of coronaviruses, is a promising target for development of broad-spectrum antiviral drugs 0.07</td>\n",
       "      <td>0.071739</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-14</td>\n",
       "      <td>Associations of clinical characteristics and antiviral drugs with viral RNA clearance in patients with COVID-19 in Guangzhou, China: a retrospective cohort study</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.09.20058941</td>\n",
       "      <td>conclusion: in patients with covid-19, isolation for a minimum of 21 days after onset of illness may be warranted, while the use of antiviral drugs does not enhance viral rna clearance 0.07 associations of clinical characteristics and antiviral drugs with viral rna clearance in patients with covid-19 in guangzhou, china: a retrospective cohort study 0.07</td>\n",
       "      <td>0.072727</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-14</td>\n",
       "      <td>Dos terapias conocidas podrían ser efectivas como adyuvantes en el paciente crítico infectado por COVID-19</td>\n",
       "      <td>https://doi.org/10.1016/j.redar.2020.03.004</td>\n",
       "      <td>unfortunately, there is not yet a specific vaccine or effective antiviral drug for treating covid-19 0.23</td>\n",
       "      <td>0.233333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-11</td>\n",
       "      <td>Key to successful treatment of COVID-19: accurate identification of severe risks and early intervention of disease progression</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.06.20054890</td>\n",
       "      <td>basic principles of early intervention treatment of covid-19: on the premise of no effective antiviral drugs, treatment is based on supportive and symptomatic therapy (albumin supplementation, supplement of potassium, supplement blood plasma, etc 0.07</td>\n",
       "      <td>0.065152</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-11</td>\n",
       "      <td>Analysis of the mutation dynamics of SARS-CoV-2 reveals the spread history and emergence of RBD mutant with lower ACE2 binding affinity</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.09.034942</td>\n",
       "      <td>the spike (s) protein encoding gene of sars-cov-2 is found relatively more conserved than other protein-encoding genes, which is a good indication for the ongoing antiviral drug and vaccine development 0.17</td>\n",
       "      <td>0.166667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-10</td>\n",
       "      <td>Structure of the RNA-dependent RNA polymerase from COVID-19 virus</td>\n",
       "      <td>https://doi.org/10.1126/science.abb7498</td>\n",
       "      <td>the rna-dependent rna polymerase (rdrp, also named nsp12) is the central component of coronaviral replication/transcription machinery and appears to be a primary target for the antiviral drug, remdesivir 0.07</td>\n",
       "      <td>0.067857</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-09</td>\n",
       "      <td>The IMPDH inhibitor merimepodib suppresses SARS-CoV-2 replication in vitro</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.07.028589</td>\n",
       "      <td>the impdh inhibitor merimepodib (mmpd) is an investigational antiviral drug that acts as a noncompetitive inhibitor of impdh 0.21</td>\n",
       "      <td>0.211111</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-09</td>\n",
       "      <td>Immunoglobulin fragment F(ab’)2 against RBD potently neutralizes SARS-CoV-2 in vitro</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.07.029884</td>\n",
       "      <td>so far, there is none vaccines or specific antiviral drugs approved for that 0.09</td>\n",
       "      <td>0.088462</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-09</td>\n",
       "      <td>Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.08.032763</td>\n",
       "      <td>the replication of sars-cov-2 requires the viral rna-dependent rna polymerase (rdrp), a direct target of the antiviral drug, remdesivir 0.08</td>\n",
       "      <td>0.076316</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-02</td>\n",
       "      <td>Variable Macro X Domain of SARS-CoV-2 Retains the Ability to Bind ADP-ribose</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.31.014639</td>\n",
       "      <td>abstractthe virus that causes covid-19, sars-cov-2, has a large rna genome that encodes numerous proteins that might be targets for antiviral drugs 0.07</td>\n",
       "      <td>0.072727</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-31</td>\n",
       "      <td>The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future</td>\n",
       "      <td>https://doi.org/10.1016/j.micinf.2020.02.002</td>\n",
       "      <td>to date, there are no clinically approved vaccines or antiviral drugs available for these human coronavirus infections 0.08</td>\n",
       "      <td>0.079412</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-31</td>\n",
       "      <td>Computational Design of Peptides to Block Binding of the SARS-CoV-2 Spike Protein to Human ACE2</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.28.013607</td>\n",
       "      <td>making the problem worse, there is no specific antiviral drug that can be used to treat covid-19 to date 0.21  therefore, molecules that can block sars-cov-2 from binding to hace2 may potentially prevent the virus from entering human cells and serve as an effective antiviral drug 0.18</td>\n",
       "      <td>0.205263</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-31</td>\n",
       "      <td>SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes</td>\n",
       "      <td>https://doi.org/10.1016/j.hrthm.2020.03.024</td>\n",
       "      <td>depending on the inherited defect involved, these patients may be susceptible to pro-arrhythmic effects of covid-19-related issues such as fever, stress, electrolyte disturbances and use of antiviral drugs 0.07</td>\n",
       "      <td>0.067857</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-30</td>\n",
       "      <td>Medical treatment of 55 patients with COVID-19 from seven cities in northeast China who fully recovered: a single-center, retrospective, observational study</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.28.20045955</td>\n",
       "      <td>interpretation: given the 100% recovery rate, early administration of antiviral drugs can be considered 0.09</td>\n",
       "      <td>0.085714</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-30</td>\n",
       "      <td>Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model</td>\n",
       "      <td>https://doi.org/10.1016/j.csbj.2020.03.025</td>\n",
       "      <td>overall, we suggest that the list of antiviral drugs identified by the mt-dti model should be considered, when establishing effective treatment strategies for sars-cov-2 0.07 predicting commercially available antiviral drugs that may act on the novel coronavirus (sars-cov-2) through a drug-target interaction deep learning model 0.08</td>\n",
       "      <td>0.075000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-28</td>\n",
       "      <td>Structure-Based Design, Synthesis and Biological Evaluation of Peptidomimetic Aldehydes as a Novel Series of Antiviral Drug Candidates Targeting the SARS-CoV-2 Main Protease</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.25.996348</td>\n",
       "      <td>structure-based design, synthesis and biological evaluation of peptidomimetic aldehydes as a novel series of antiviral drug candidates targeting the sars-cov-2 main protease 0.19</td>\n",
       "      <td>0.190909</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-27</td>\n",
       "      <td>Codon usage and evolutionary rates of the 2019-nCoV genes</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.25.006569</td>\n",
       "      <td>conversely, genes encoding nucleocapsid (n), viral replicase and spike proteins are important targets for the development of vaccines and antiviral drugs, tend to evolve faster as compared to other ones 0.07</td>\n",
       "      <td>0.066667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-24</td>\n",
       "      <td>Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.21.20040691</td>\n",
       "      <td>background: sars-cov-2 is a novel human coronavirus, there is no specific antiviral drugs 0.09</td>\n",
       "      <td>0.088462</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-22</td>\n",
       "      <td>A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.22.002386</td>\n",
       "      <td>there are currently no antiviral drugs with proven efficacy nor are there vaccines for its prevention 0.08</td>\n",
       "      <td>0.081250</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-21</td>\n",
       "      <td>COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives</td>\n",
       "      <td>https://doi.org/10.1016/j.molmed.2020.02.008</td>\n",
       "      <td>with no antiviral drugs nor vaccines, and the presence of carriers without obvious symptoms, traditional public health intervention measures are significantly less effective 0.07</td>\n",
       "      <td>0.071739</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-20</td>\n",
       "      <td>A prospect on the use of antiviral drugs to control local outbreaks of COVID-19</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.19.20038182</td>\n",
       "      <td>objective: investigate the impact of using antiviral drugs to control local outbreaks of covid-19 0.09  results: the use of an antiviral drug, in combination with contact tracing, quarantine and isolation, results in a significant decrease of the mean final size and the peak incidence of local outbreaks of covid-19, provided delays in contact tracing are small 0.06  conclusions: integrating antiviral drugs together with contact tracing and quarantine is predicted through this model to be an effective tool for the control of local outbreaks of covid-19 0.07 a prospect on the use of antiviral drugs to control local outbreaks of covid-19 0.09</td>\n",
       "      <td>0.085714</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-20</td>\n",
       "      <td>Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.20.999730</td>\n",
       "      <td>drug repositioning represents the only feasible option to address this global challenge and a panel of fifty fda-approved drugs that have been pre-selected by an assay of sars-cov was screened to identify potential antiviral drug candidates against sars-cov-2 infection 0.18 identification of antiviral drug candidates against sars-cov-2 from fda-approved drugs 0.3</td>\n",
       "      <td>0.300000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-20</td>\n",
       "      <td>A brief review of antiviral drugs evaluated in registered clinical trials for COVID-19</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.18.20038190</td>\n",
       "      <td>we included interventional clinical trials focusing on patients with covid-19 and assessing antiviral drugs or agents 0.08  funding: nonea brief review of antiviral drugs evaluated in registered clinical trials for covid-19 0.09</td>\n",
       "      <td>0.085714</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-17</td>\n",
       "      <td>Structure of RNA-dependent RNA polymerase from 2019-nCoV, a major antiviral drug target</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.16.993386</td>\n",
       "      <td>the rna-dependent rna polymerase (rdrp, also named nsp12), which catalyzes the synthesis of viral rna, is a key component of coronaviral replication/transcription machinery and appears to be a primary target for the antiviral drug, remdesivir 0.06 structure of rna-dependent rna polymerase from 2019-ncov, a major antiviral drug target 0.27</td>\n",
       "      <td>0.266667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-16</td>\n",
       "      <td>Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2</td>\n",
       "      <td>https://doi.org/10.1038/s41421-020-0153-3</td>\n",
       "      <td>in this study, we present an integrative, antiviral drug repurposing methodology implementing a systems pharmacology-based network medicine platform, quantifying the interplay between the hcov–host interactome and drug targets in the human protein–protein interaction network 0.19</td>\n",
       "      <td>0.188235</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-16</td>\n",
       "      <td>Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China</td>\n",
       "      <td>https://doi.org/10.1093/cid/ciaa270</td>\n",
       "      <td>refractory covid-19 patients were more likely to receive oxygen, mechanical ventilation, expectorant, and adjunctive treatment including corticosteroid, antiviral drugs and immune enhancer (p<0 0.07</td>\n",
       "      <td>0.071739</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-16</td>\n",
       "      <td>COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses</td>\n",
       "      <td>https://doi.org/10.1016/j.jare.2020.03.005</td>\n",
       "      <td>there is no clinically approved antiviral drug or vaccine available to be used against covid-19 0.23  however, few broad-spectrum antiviral drugs have been evaluated against covid-19 in clinical trials, resulted in clinical recovery 0.08</td>\n",
       "      <td>0.233333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-14</td>\n",
       "      <td>SARS-CoV-2 invades host cells via a novel route: CD147-spike protein</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.14.988345</td>\n",
       "      <td>summarycurrently, covid-19 caused by severe acute respiratory syndrome coronavirus 2 (sars-cov-2) has been widely spread around the world; nevertheless, so far there exist no specific antiviral drugs for treatment of the disease, which poses great challenge to control and contain the virus 0.06  therefore, the discovery of the new route cd147-sp for sars-cov-2 invading host cells provides a critical target for development of specific antiviral drugs 0.07</td>\n",
       "      <td>0.071739</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-08</td>\n",
       "      <td>AI-aided design of novel targeted covalent inhibitors against SARS-CoV-2</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.03.972133</td>\n",
       "      <td>as a key enzyme in the life-cycle of coronavirus, the 3c-like main protease (3clpro or mpro) is the most attractive for antiviral drug design 0.18</td>\n",
       "      <td>0.183333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-08</td>\n",
       "      <td>Substrate specificity profiling of SARS-CoV-2 Mpro protease provides basis for anti-COVID-19 drug design</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.07.981928</td>\n",
       "      <td>currently, there is no effective antiviral treatment for covid-19, therefore research efforts are focused on the rapid development of vaccines and antiviral drugs 0.09  the sars-cov-2 mpro protease constitutes one of the most attractive antiviral drug targets 0.25</td>\n",
       "      <td>0.253846</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-07</td>\n",
       "      <td>Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.06.977876</td>\n",
       "      <td>viral nucleocapsid protein is a potential antiviral drug target, serving multiple critical functions during the viral life cycle 0.21</td>\n",
       "      <td>0.211111</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-05</td>\n",
       "      <td>Taking the right measures to control COVID-19</td>\n",
       "      <td>https://doi.org/10.1016/s1473-3099(20)30152-3</td>\n",
       "      <td>8 fifth, who has made it clear that there are currently no known effective treatments for covid-19 and does not recommend the use of antiviral drugs, antibiotics, glucocorticoids, or traditional chinese medicine 0.07</td>\n",
       "      <td>0.065625</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-05</td>\n",
       "      <td>Clinical trial analysis of 2019-nCoV therapy registered in China</td>\n",
       "      <td>https://doi.org/10.1002/jmv.25733</td>\n",
       "      <td>with more and more patients diagnosed, china has carried out more than one hundred clinical studies of new coronavirus infection, including antiviral drugs, antimalarial drugs, glucocorticoids, plasma therapy, virus vaccine and other western drugs, while chinese medicine researches accounted for half of studies 0.06</td>\n",
       "      <td>0.061628</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-03</td>\n",
       "      <td>Computational Prediction of Mutational Effects on the SARS-CoV-2 Binding by Relative Free Energy Calculations</td>\n",
       "      <td>https://doi.org/10.26434/chemrxiv.11902623.v2</td>\n",
       "      <td>in addition, our free energy calculations provide insight into the infectious ability of viruses on a physical basis, and also provide useful information for the design of antiviral drugs 0.07</td>\n",
       "      <td>0.067241</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-20</td>\n",
       "      <td>X-ray Structure of Main Protease of the Novel Coronavirus SARS-CoV-2 Enables Design of α-Ketoamide Inhibitors</td>\n",
       "      <td>https://doi.org/10.1101/2020.02.17.952879</td>\n",
       "      <td>these structures will form the basis for further development of these compounds to antiviral drugs 0.08</td>\n",
       "      <td>0.083333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-13</td>\n",
       "      <td>ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Damage After 2019-nCoV Infection</td>\n",
       "      <td>https://doi.org/10.1101/2020.02.12.20022418</td>\n",
       "      <td>our results indicate that renal function evaluation and special care should be performed in 2019-ncov patients during clinical work, because of the kidney damage caused by virus and antiviral drugs with certain renal toxicity 0.06</td>\n",
       "      <td>0.064706</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-11</td>\n",
       "      <td>Old Weapon for New Enemy: Drug Repurposing for Treatment of Newly Emerging Viral Diseases</td>\n",
       "      <td>https://doi.org/10.1007/s12250-020-00204-7</td>\n",
       "      <td>gengfu xiao, wu zhong and zhihong hu, the antiviral efficiency of the fda-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine (cq) and two well-known broad-spectrum antiviral drugs remdesivir (rdv, gs-5734) and favipiravir (t-705) were evaluated against a clinical isolate of 2019-ncov in a cell culture infection model (wang et al 0.07</td>\n",
       "      <td>0.070000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-05</td>\n",
       "      <td>Network-based Drug Repurposing for Human Coronavirus</td>\n",
       "      <td>https://doi.org/10.1101/2020.02.03.20020263</td>\n",
       "      <td>in this study, we present an integrative, antiviral drug repurposing methodology implementing a systems pharmacology-based network medicine platform, quantifying the interplay between the hcov-host interactome and drug targets in the human protein-protein interaction network 0.19</td>\n",
       "      <td>0.188235</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-02</td>\n",
       "      <td>Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China through a drug-target interaction deep learning model</td>\n",
       "      <td>https://doi.org/10.1101/2020.01.31.929547</td>\n",
       "      <td>overall, we suggest that the list of antiviral drugs identified by the mt-dti model should be considered, when establishing effective treatment strategies for 2019-ncov 0.07 predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-ncov), wuhan, china through a drug-target interaction deep learning model 0.07</td>\n",
       "      <td>0.072727</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020</td>\n",
       "      <td>Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China | Clinical Infectious Diseases | Oxford Academic</td>\n",
       "      <td>https://doi.org/no data provided</td>\n",
       "      <td>refractory covid-19 patients were more likely to receive oxygen, mechanical ventilation, expectorant, and adjunctive treatment including corticosteroid, antiviral drugs and immune enhancer (p<0 0.07</td>\n",
       "      <td>0.071739</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020</td>\n",
       "      <td>Potential antiviral therapeutics for 2019 Novel Coronavirus</td>\n",
       "      <td>https://doi.org/10.3760/cma.j.issn.1001-0939.2020.0002</td>\n",
       "      <td>antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc 0.09</td>\n",
       "      <td>0.085714</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020</td>\n",
       "      <td>Management and clinical thinking of Coronavirus Disease 2019</td>\n",
       "      <td>https://doi.org/10.3760/cma.j.issn.1007-3418.2020.0002</td>\n",
       "      <td>how to effectively control the spread of covid-19? when does the population infection rate rise to its peak? what will eventually be the number of infected patients? how to make early diagnosis? what effective antiviral drugs are available? how to effectively treat with existing drugs? can it successfully improve the survival rate of critically patients? in response to the above questions, we put forward corresponding suggestions and reflections from the perspective of the infectious clinician 0.06</td>\n",
       "      <td>0.056667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020</td>\n",
       "      <td>Strategies for the development of drugs targeting novel coronavirus 2019-nCoV</td>\n",
       "      <td>https://doi.org/no data provided</td>\n",
       "      <td>approaches to the development of anti-2019-ncov include screening existing broad-spectrum antiviral drugs, repositioning of readily available clinical compounds, and &lt;italic&gt;de novo&lt;/italic&gt; development of novel and specific agents for 2019-ncov 0.07</td>\n",
       "      <td>0.067241</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020</td>\n",
       "      <td>The report of two cases infection with novel coronavirus (2019-ncov) after kidney transplantation and the association literature analyzation</td>\n",
       "      <td>https://doi.org/no data provided</td>\n",
       "      <td>at present, there are no antiviral drugs and symptomatic treatment is the main choice 0.09</td>\n",
       "      <td>0.085714</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020</td>\n",
       "      <td>Experience of treating severe cases of 2019 novel coronavirus pneumonia in Changde area</td>\n",
       "      <td>https://doi.org/no data provided</td>\n",
       "      <td>the patients relieved through respiratory support, hemodynamics management, nutritional support, the application of antiviral drugs, analgesic and sedation 0.08  however, the trade-off between the risk of intestinal function and nutritional support in patients with mechanical ventilation and the antiviral benefits of kaletra needed to be reevaluated, the optimized way of analgesia and sedation was adopted, at the same time, the usage and side effects of antiviral drugs should be paid attention to 0.07</td>\n",
       "      <td>0.077778</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020</td>\n",
       "      <td>Clinical research progresss of antiviral drugs for the novel coronavirus pneumonia</td>\n",
       "      <td>https://doi.org/no data provided</td>\n",
       "      <td>however, there are no definite and effective antiviral drugs for the novel coronavirus pneumonia all around the world 0.08  therefore, this article aims to provide new idea for the effective treatment of the novel coronavirus pneumonia by summarizing the basic research and clinical progress of antiviral drugs at home and abroad 0.07 clinical research progresss of antiviral drugs for the novel coronavirus pneumonia 0.1</td>\n",
       "      <td>0.095455</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "antivirus drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020</td>\n",
       "      <td>Pharmacotherapeutics for the New Coronavirus Pneumonia</td>\n",
       "      <td>https://doi.org/10.3760/cma.j.issn.1001-0939.2020.0012</td>\n",
       "      <td>combination of ribavirin and interferon-α is recommended by the 5(th) edition national health commission's regimen (revised edition) because of the effect on mers (middle east respiratory syndrome), and the effectiveness of lopinavir/ritonavir and remdisivir needs to be confirmed by randomized controlled trial (rct), given the situation of no specific antivirus drug on ncp is unavailable 0.14</td>\n",
       "      <td>0.136364</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "approved drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-06-30</td>\n",
       "      <td>The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro</td>\n",
       "      <td>https://doi.org/10.1016/j.antiviral.2020.104787</td>\n",
       "      <td>the fda-approved drug ivermectin inhibits the replication of sars-cov-2 in vitro 0.1</td>\n",
       "      <td>0.095455</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-05-01</td>\n",
       "      <td>Anti-HCV, nucleotide inhibitors, repurposing against COVID-19</td>\n",
       "      <td>https://doi.org/10.1016/j.lfs.2020.117477</td>\n",
       "      <td>additionally, the newly emerged wuhan hcov rdrp model is targeted by anti-polymerase drugs, including the approved drugs sofosbuvir and ribavirin 0.08</td>\n",
       "      <td>0.075000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-30</td>\n",
       "      <td>COVID-19: combining antiviral and anti-inflammatory treatments</td>\n",
       "      <td>https://doi.org/10.1016/s1473-3099(20)30132-8</td>\n",
       "      <td>we identified a group of approved drugs that could inhibit clathrin-mediated endocytosis and thereby inhibit viral infection of cells (appendix) 0.08</td>\n",
       "      <td>0.075000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-20</td>\n",
       "      <td>Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19</td>\n",
       "      <td>https://doi.org/10.1016/j.apsb.2020.04.008</td>\n",
       "      <td>food and drug administration (fda) approved drug library, we identified an anticoagulation agent dipyridamole (dip) in silico, which suppressed sars-cov-2 replication in vitro 0.23</td>\n",
       "      <td>0.230435</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-15</td>\n",
       "      <td>Multidrug treatment with nelfinavir and cepharanthine against COVID-19</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.14.039925</td>\n",
       "      <td>we screened a panel of already-approved drugs in a cell culture model of severe acute respiratory syndrome coronavirus 2 (sars-cov-2) and identified two new antiviral agents: the hiv protease inhibitor nelfinavir and the anti-inflammatory drug cepharanthine 0.06</td>\n",
       "      <td>0.063889</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-14</td>\n",
       "      <td>Repurposing Didanosine as a Potential Treatment for COVID-19 Using Single-Cell RNA Sequencing Data</td>\n",
       "      <td>https://doi.org/10.1128/msystems.00297-20</td>\n",
       "      <td>there is no approved drug or vaccine for covid-19, although more than 10 clinical trials have been launched to test potential drugs 0.19</td>\n",
       "      <td>0.190909</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-14</td>\n",
       "      <td>Human organs-on-chips as tools for repurposing approved drugs as potential influenza and COVID19 therapeutics in viral pandemics</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.13.039917</td>\n",
       "      <td>these airway chips, which contain human lung epithelial cells that express high levels of ace2 and tmprss2, were then used to assess the inhibitory activities of 7 clinically approved drugs (chloroquine, arbidol, toremifene, clomiphene, amodiaquine, verapamil, and amiodarone) that we found inhibit infection by viral pseudoparticles expressing sars-cov-2 spike protein in human huh-7 cells, and others recently showed suppress infection by native sars-cov-2 in vero cells 0.06 human organs-on-chips as tools for repurposing approved drugs as potential influenza and covid19 therapeutics in viral pandemics 0.08</td>\n",
       "      <td>0.079412</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-08</td>\n",
       "      <td>Nelfinavir inhibits replication of severe acute respiratory syndrome coronavirus 2 in vitro.</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.06.026476</td>\n",
       "      <td>therefore, it is urgently needed to identify effective antiviral agents for the treatment of this disease, and several approved drugs such as lopinavir have been evaluated 0.07</td>\n",
       "      <td>0.069231</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-05</td>\n",
       "      <td>In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.03.023846</td>\n",
       "      <td>repurposing of approved drugs is a strategy that can bypass the time consuming stages of drug development 0.22  in this study, we screened the prestwick chemical library® composed of 1,520 approved drugs in an infected cell-based assay 0.08</td>\n",
       "      <td>0.217647</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-05</td>\n",
       "      <td>Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.04.020925</td>\n",
       "      <td>the identification of any clinically approved drug that could be repurposed to combat covid-19 would allow the rapid implementation of potentially life-saving procedures to complement social distancing and isolation protocols 0.17</td>\n",
       "      <td>0.166667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-31</td>\n",
       "      <td>Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus</td>\n",
       "      <td>https://doi.org/10.6026/97320630016236</td>\n",
       "      <td>therefore, it is of interest to study the binding features of 1615 fda approved drugs with the recently known 2019-ncov main protease structure having high sequence homology with that from sars-cov 0.07 molecular docking and dynamics simulation of fda approved drugs with the main protease from 2019 novel coronavirus 0.08</td>\n",
       "      <td>0.079412</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-27</td>\n",
       "      <td>FDA approved drugs with broad anti-coronaviral activity inhibit SARS-CoV-2 in vitro</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.25.008482</td>\n",
       "      <td>current treatments for covid-19 are limited to supportive therapies and off-label use of fda approved drugs (3) 0.08  here, we present data on 20 fda approved drugs tested for antiviral activity against sars-cov-2 that we have previously found to inhibit sars-cov and mers-cov (4) 0.07 fda approved drugs with broad anti-coronaviral activity inhibit sars-cov-2 in vitro 0.1</td>\n",
       "      <td>0.095455</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-24</td>\n",
       "      <td>First Clinical Study Using HCV Protease Inhibitor Danoprevir to Treat Naive and Experienced COVID-19 Patients</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.22.20034041</td>\n",
       "      <td>as coronavirus disease 2019 (covid-19) outbreak, caused by the severe acute respiratory syndrome coronavirus-2 (sars-cov-2), started in china in january, 2020, repurposing approved drugs is emerging as important therapeutic options 0.07</td>\n",
       "      <td>0.066667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-20</td>\n",
       "      <td>Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.20.999730</td>\n",
       "      <td>drug repositioning represents the only feasible option to address this global challenge and a panel of fifty fda-approved drugs that have been pre-selected by an assay of sars-cov was screened to identify potential antiviral drug candidates against sars-cov-2 infection 0.08 identification of antiviral drug candidates against sars-cov-2 from fda-approved drugs 0.1</td>\n",
       "      <td>0.100000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-20</td>\n",
       "      <td>Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.18.997585</td>\n",
       "      <td>using the same molecular insight, we selected the active triphosphate forms of three other anti-viral agents, alovudine, azt (an fda approved hiv/aids drug) and tenofovir alafenamide (taf, an fda approved drug for hiv and hepatitis b) for evaluation as inhibitors of sars-cov-2 rdrp 0.17</td>\n",
       "      <td>0.169767</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-20</td>\n",
       "      <td>A brief review of antiviral drugs evaluated in registered clinical trials for COVID-19</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.18.20038190</td>\n",
       "      <td>background: although a number of antiviral agents have been evaluated for coronaviruses there are no approved drugs available 0.08</td>\n",
       "      <td>0.077778</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-08</td>\n",
       "      <td>AI-aided design of novel targeted covalent inhibitors against SARS-CoV-2</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.03.972133</td>\n",
       "      <td>abstractthe focused drug repurposing of known approved drugs (such as lopinavir/ritonavir) has been reported failed for curing sars-cov-2 infected patients 0.2</td>\n",
       "      <td>0.200000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-06</td>\n",
       "      <td>Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model</td>\n",
       "      <td>https://doi.org/10.1097/cm9.0000000000000797</td>\n",
       "      <td>this study aims to repurpose the clinically approved drugs for the treatment of coronavirus disease 2019 (covid-19) in a 2019-ncov-related coronavirus model 0.07  two libraries of 2406 clinically approved drugs were screened for their ability to inhibit cytopathic effects on vero e6 cells by gx_p2v infection 0.07 repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model 0.08</td>\n",
       "      <td>0.079412</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-02</td>\n",
       "      <td>Screening of FDA-approved drugs using a MERS-CoV clinical isolate from South Korea identifies potential therapeutic options for COVID-19</td>\n",
       "      <td>https://doi.org/10.1101/2020.02.25.965582</td>\n",
       "      <td>to address these unmet medical needs, we used a south korean mers-cov clinical isolate and screened 5,406 compounds, including united states food and drug administration (fda)-approved drugs and bioactive molecules, for their activity against the isolate 0.06</td>\n",
       "      <td>0.063889</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-29</td>\n",
       "      <td>Therapeutic effects of dipyridamole on COVID-19 patients with coagulation dysfunction</td>\n",
       "      <td>https://doi.org/10.1101/2020.02.27.20027557</td>\n",
       "      <td>we screened an fda approved drug library and found that an anticoagulant agent dipyridamole (dip) suppressed hcov-19 replication at an ec50 of 100 nm in vitro 0.18</td>\n",
       "      <td>0.176923</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-27</td>\n",
       "      <td>Structure of Mpro from COVID-19 virus and discovery of its inhibitors</td>\n",
       "      <td>https://doi.org/10.1101/2020.02.26.964882</td>\n",
       "      <td>next, through a combination of structure-based virtual and high-throughput screening, we assayed over 10,000 compounds including approved drugs, drug candidates in clinical trials, and other pharmacologically active compounds as inhibitors of mpro 0.16</td>\n",
       "      <td>0.162500</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-21</td>\n",
       "      <td>Functional pangenome analysis suggests inhibition of the protein E as a readily available therapy for COVID-2019</td>\n",
       "      <td>https://doi.org/10.1101/2020.02.17.952895</td>\n",
       "      <td>given that our results demonstrate that the protein e subcluster for the sars clade is quasi-identical for the key functional regions of sars-cov-1 and sars-cov-2, we conclude that use of approved drugs shown to act as sars e protein inhibitors can help prevent further casualties from covid-2019 while vaccines and other preventive measures are being developed 0.06</td>\n",
       "      <td>0.058929</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-20</td>\n",
       "      <td>Potential inhibitors against papain-like protease of novel coronavirus (SARS-CoV-2) from FDA approved drugs</td>\n",
       "      <td>https://doi.org/10.26434/chemrxiv.11860011.v2</td>\n",
       "      <td>0 citation information: arya, rimanshee; das, amit; prashar, vishal; kumar, mukesh (2020): potential inhibitors against papain-like protease of novel coronavirus (sars-cov-2) from fda approved drugs 0.07  in this scenario, there is a need to utilize the existing repertoire of fda approved drugs to treat the disease 0.08  we chose one such crucial viral protein, the papain-like protease (plpro), to screen the fda approved drugs in silico 0.08  in our docking studies, sixteen fda approved drugs, including chloroquine and formoterol, was found to bind the target enzyme with significant affinity and good geometry, suggesting their potential to be utilized against the virus 0.06  in this scenario, there is a need to utilize the existing repertoire of fda approved drugs to treat the disease 0.08  we chose one such crucial viral protein, the papain-like protease (plpro), to screen the fda approved drugs in silico 0.08  in our docking studies, sixteen fda approved drugs, including chloroquine and formoterol, was found to bind the target enzyme with significant affinity and good geometry, suggesting their potential to be utilized against the virus 0.06 potential inhibitors against papain-like protease of novel coronavirus (sars-cov-2) from fda approved drugs 0.09</td>\n",
       "      <td>0.088462</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-13</td>\n",
       "      <td>Potentially highly potent drugs for 2019-nCoV</td>\n",
       "      <td>https://doi.org/10.1101/2020.02.05.936013</td>\n",
       "      <td>we found that many fda approved drugs are potentially highly potent to 2019-ncov 0.09</td>\n",
       "      <td>0.088462</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-10</td>\n",
       "      <td>Artificial intelligence finds drugs that could fight the new coronavirus</td>\n",
       "      <td>https://doi.org/10.1021/cen-09806-scicon1</td>\n",
       "      <td>4, researchers from the ai drug discovery company benevolentai and imperial college london reported that they had used ai software to find an already-approved drug that might limit the virus’s ability to infect people (lancet 2020, doi: 10 0.08</td>\n",
       "      <td>0.076316</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-01-31</td>\n",
       "      <td>Nucleotide Analogues as Inhibitors of Viral Polymerases</td>\n",
       "      <td>https://doi.org/10.1101/2020.01.30.927574</td>\n",
       "      <td>based on our molecular insight that the hepatitis c virus and the coronavirus use a similar viral genome replication mechanism, we reasoned that the fda-approved drug epclusa (sofosbuvir/velpatasvir) for the treatment of hepatitis c will also inhibit the above coronaviruses, including 2019-ncov 0.06</td>\n",
       "      <td>0.061905</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "arb drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-03-27</td>\n",
       "      <td>Anti-hypertensive Angiotensin II receptor blockers associated to mitigation of disease severity in elderly COVID-19 patients</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.20.20039586</td>\n",
       "      <td>findings among the elderly (age>65) covid-19 patients with hypertension comorbidity, the risk of covid-19-s (severe disease) was significantly decreased in patients who took arb drugs prior to hospitalization compared to patients who took no drugs (or=0 0.06</td>\n",
       "      <td>0.063889</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "available drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-14</td>\n",
       "      <td>Sphingolipid Biosynthesis Inhibition As A Host Strategy Against Diverse Pathogens</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.10.035683</td>\n",
       "      <td>our study demonstrates that numerous readily available drugs molecularly function highly similar to chloroquine, which suggests they might be considered for further pre-clinical investigation in the context of sars-cov-2 0.07</td>\n",
       "      <td>0.067241</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-09</td>\n",
       "      <td>A possible strategy to fight COVID-19: Interfering with spike glycoprotein trimerization</td>\n",
       "      <td>https://doi.org/10.1016/j.bbrc.2020.04.007</td>\n",
       "      <td>the presence of some druggable pockets at these interfaces suggested that some of the available drugs in drug bank could destabilize the quaternary spike glycoprotein formation by binding to these pockets, therefore interfering with covid-19 life cycle 0.15</td>\n",
       "      <td>0.154054</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-07</td>\n",
       "      <td>Repurposing Therapeutics for COVID-19: Rapid Prediction of Commercially available drugs through Machine Learning and Docking</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.05.20054254</td>\n",
       "      <td>repurposing therapeutics for covid-19: rapid prediction of commercially available drugs through machine learning and docking 0.08</td>\n",
       "      <td>0.083333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-01</td>\n",
       "      <td>Molecular Docking Analysis Of Some Phytochemicals On Two SARS-CoV-2 Targets</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.31.017657</td>\n",
       "      <td>at the moment there is no available drug(s) and vaccine(s) for the treatment or prevention of covid-19 0.08</td>\n",
       "      <td>0.079412</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-30</td>\n",
       "      <td>Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model</td>\n",
       "      <td>https://doi.org/10.1016/j.csbj.2020.03.025</td>\n",
       "      <td>in this study, we used our pre-trained deep learning-based drug-target interaction model called molecule transformer-drug target interaction (mt-dti) to identify commercially available drugs that could act on viral proteins of sars-cov-2 0.07</td>\n",
       "      <td>0.066129</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-25</td>\n",
       "      <td>Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyond</td>\n",
       "      <td>https://doi.org/10.1007/s11095-020-02799-8</td>\n",
       "      <td>this is a small-molecule orally bioavailable drug that was originally discovered in the usa and is currently used clinically as an antiviral in russia and the ukraine 0.07</td>\n",
       "      <td>0.068519</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-02</td>\n",
       "      <td>Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China through a drug-target interaction deep learning model</td>\n",
       "      <td>https://doi.org/10.1101/2020.01.31.929547</td>\n",
       "      <td>in this study, we used our pretrained deep learning-based drug-target interaction model called molecule transformer-drug target interaction (mt-dti) to identify commercially available drugs that could act on viral proteins of 2019-ncov 0.07</td>\n",
       "      <td>0.066129</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "candidate drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-22</td>\n",
       "      <td>Structural Basis of SARS-CoV-2 Spike Protein Priming by TMPRSS2</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.21.052639</td>\n",
       "      <td>the present study aims to investigate the conformational details of complex between tmprss2 and sars-cov-2 spike protein, in order to discern the finer details of the priming of viral spike and to point candidate drug targets 0.16  in summary, the present study provide structural characteristics of molecular complex between human tmprss2 and sars-cov-2 spike protein and points to the candidate drug targets that could further be exploited to direct structure base drug designing 0.18</td>\n",
       "      <td>0.183333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-15</td>\n",
       "      <td>Convalescent plasma: A possible treatment of COVID-19 in India</td>\n",
       "      <td>https://doi.org/10.1016/j.mjafi.2020.04.006</td>\n",
       "      <td>there are no current effective strategies to prevent the spread, other than minimizing contact through social distancing, while no fully effective drugs to prevent or treat covid-19 exist, although several candidate drugs and repurposed antiviral and immune-modulating pharmacotherapies are being tested or in compassionate use 0.06</td>\n",
       "      <td>0.061111</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-08</td>\n",
       "      <td>Nelfinavir inhibits replication of severe acute respiratory syndrome coronavirus 2 in vitro.</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.06.026476</td>\n",
       "      <td>these results suggest that nelfinavir is a potential candidate drug for the treatment of covid-19 and should be assessed in patients with covid-19 0.19</td>\n",
       "      <td>0.186957</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-01</td>\n",
       "      <td>Molecular Docking Analysis Of Some Phytochemicals On Two SARS-CoV-2 Targets</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.31.017657</td>\n",
       "      <td>our data suggest silibinin a repurposing candidate drug may have multitarget activity against sars-cov-2 0.24</td>\n",
       "      <td>0.242857</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-12</td>\n",
       "      <td>The inhaled corticosteroid ciclesonide blocks coronavirus RNA replication by targeting viral NSP15</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.11.987016</td>\n",
       "      <td>these observations suggest that the effect of ciclesonide was specific to coronavirus, suggesting this is a candidate drug for treatment of patients suffering mers or covid-19 0.18</td>\n",
       "      <td>0.176923</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-01-29</td>\n",
       "      <td>Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines</td>\n",
       "      <td>https://doi.org/10.1101/2020.01.29.924100</td>\n",
       "      <td>with the hope to identify candidate drugs for 2019-ncov, we adopted a computational approach to screen for available commercial medicines which may function as inhibitors for the mpro of 2019-ncov 0.07</td>\n",
       "      <td>0.066667</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "clinical drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-03-05</td>\n",
       "      <td>Insight Derived from Molecular Docking and Molecular Dynamics Simulations into the Binding Interactions Between HIV-1 Protease Inhibitors and SARS-CoV-2 3CLpro</td>\n",
       "      <td>https://doi.org/10.26434/chemrxiv.11932995.v1</td>\n",
       "      <td>since it has been reported that the hiv-1 protease inhibitors can be used as anti-sars drugs by tegarting sars-cov 3clpro, we choose six approved anti-hiv-1 drugs to investigate their binding interactions between 3clpro, and to evaluate their potential to become clinical drugs for the new coronavirus pneumonia (covid19) caused by sars-cov-2 infection 0.06  our results show that darunavir has the best binding affinity with sars-cov-2 and sars-cov 3clpro among all inhibitors, indicating it has the potential to become an anti-covid-19 clinical drug 0.17</td>\n",
       "      <td>0.168966</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-11</td>\n",
       "      <td>Old Weapon for New Enemy: Drug Repurposing for Treatment of Newly Emerging Viral Diseases</td>\n",
       "      <td>https://doi.org/10.1007/s12250-020-00204-7</td>\n",
       "      <td>from the in vitro results, these two compounds appear promising to be transformed into clinical drugs for treatment of 2019-ncov infections 0.07</td>\n",
       "      <td>0.073810</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-01-29</td>\n",
       "      <td>Therapeutic Drugs Targeting 2019-nCoV Main Protease by High-Throughput Screening</td>\n",
       "      <td>https://doi.org/10.1101/2020.01.28.922922</td>\n",
       "      <td>in this study, we have identified 4 small molecular drugs with high binding capacity with sars-cov main protease by high-throughput screening based on the 8,000 clinical drug libraries, all these drugs have been widely used in clinical applications with guaranteed safety, which may serve as promising candidates to treat the infection of 2019-ncov 0.16</td>\n",
       "      <td>0.156604</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020</td>\n",
       "      <td>2019-nCoV: new challenges from coronavirus</td>\n",
       "      <td>https://doi.org/10.3760/cma.j.issn.0253-9624.2020.0001</td>\n",
       "      <td>after the outbreak of this disease, chinese scientists invested a lot of energy to carry out research by developing rapid diagnostic reagents, identifying the characters of the pathogen, screening out clinical drugs that may inhibit the virus, and are rapidly developing vaccines 0.06</td>\n",
       "      <td>0.061905</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "cmt drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-03-20</td>\n",
       "      <td>Advance of Novel Coronavirus Registration Clinical Trial</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.16.20034934</td>\n",
       "      <td>cmt drugs with high research frequency are chloroquine, lopinavir / ritonavir, and i-ifn, which are all in phase 4; bi was cell therapy, plasma therapy, thymosin, and m/p-ab, which are all in early stages 0.06</td>\n",
       "      <td>0.064706</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "data provideddrug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-02-29</td>\n",
       "      <td>Drug treatment options for the 2019-new coronavirus (2019-nCoV)</td>\n",
       "      <td>https://doi.org/10.5582/bst.2020.01020</td>\n",
       "      <td>no data provideddrug treatment options for the 2019-new coronavirus (2019-ncov) 0.3</td>\n",
       "      <td>0.300000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020</td>\n",
       "      <td>Drug interaction monitoring of lopinavir / ritonavir in COVID-19 patients with cancer</td>\n",
       "      <td>https://doi.org/10.3760/cma.j.cn112138-20200219-00097</td>\n",
       "      <td>no data provideddrug interaction monitoring of lopinavir / ritonavir in covid-19 patients with cancer 0.24</td>\n",
       "      <td>0.242857</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "designed drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-21</td>\n",
       "      <td>Deep learning model can predict water binding sites on the surface of proteins using limited-resolution data</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.20.050393</td>\n",
       "      <td>not only do such molecules often fulfil critical biological functions, but also, they may alter the binding of newly designed drugs 0.07</td>\n",
       "      <td>0.07381</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "driven drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-03-12</td>\n",
       "      <td>A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.11.986836</td>\n",
       "      <td>we developed a data-driven drug repositioning framework, which applies both machine learning and statistical analysis approaches to systematically integrate and mine large-scale knowledge graph, literature and transcriptome data to discover the potential drug candidates against sars-cov-2 0.08  in summary, the parp1 inhibitor cvl218 discovered by our data-driven drug repositioning framework can serve as a potential therapeutic agent for the treatment of covid-19 0.07 a data-driven drug repositioning framework discovered a potential therapeutic agent targeting covid-19 0.09</td>\n",
       "      <td>0.091667</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "drug effects\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-14</td>\n",
       "      <td>ACE inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: a Mendelian randomization study</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.10.20059121</td>\n",
       "      <td>objectives: to use human genetic variants that proxy angiotensin-converting enzyme (ace) inhibitor drug effects and cardiovascular risk factors to provide insight into how these exposures affect lung ace2 and tmprss2 gene expression and circulating ace2 levels 0.16  variants that proxy ace inhibitor drug effects and cardiometabolic risk factors (body mass index, chronic obstructive pulmonary disease, lifetime smoking index, low-density lipoprotein cholesterol, systolic blood pressure and type 2 diabetes mellitus) were selected from publicly available genome-wide association study data (sample sizes ranging from 188,577 to 898,130 participants) 0.14</td>\n",
       "      <td>0.155556</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-12</td>\n",
       "      <td>Mechanistic modeling of the SARS-CoV-2 disease map</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.12.025577</td>\n",
       "      <td>moreover, given to the mechanistic properties of the model, the effect of potential interventions, such as knock-downs, over-expression or drug effects (currently the system models the effect of more than 8000 drugbank drugs) can be studied in specific conditions 0.15</td>\n",
       "      <td>0.151282</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-02</td>\n",
       "      <td>The within-host viral kinetics of SARS-CoV-2</td>\n",
       "      <td>https://doi.org/10.1101/2020.02.29.965418</td>\n",
       "      <td>the prcc method is used to analyze the sensitivities of model parameters and the drug effects on virus growth are also implemented to analyze the model 0.18</td>\n",
       "      <td>0.176923</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "drug labeling\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-14</td>\n",
       "      <td>A systematic review to assess seizure risk with chloroquine therapy in persons with epilepsy</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.09.20056358</td>\n",
       "      <td>however, drug labeling in the package insertion states that persons with epilepsy have the risk of chloroquine provoking seizures, and this has increased questions and anxiety in the epilepsy community 0.17</td>\n",
       "      <td>0.166667</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "drug therapy\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-08</td>\n",
       "      <td>EZH2-mediated H3K27me3 inhibits ACE2 expression</td>\n",
       "      <td>https://doi.org/10.1016/j.bbrc.2020.04.010</td>\n",
       "      <td>our discovery provides clues for pathogenesis and targeted drug therapy towards ace2 expression for prevention and adjuvant therapy of covid-19 0.25</td>\n",
       "      <td>0.250000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-30</td>\n",
       "      <td>Genetic Profiles in Pharmacogenes Indicate Personalized Drug Therapy for COVID-19</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.23.20041350</td>\n",
       "      <td>genetic profiles in pharmacogenes indicate personalized drug therapy for covid-19 0.3</td>\n",
       "      <td>0.300000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-09</td>\n",
       "      <td>Liver and Kidney Injuries in COVID-19 and Their Effects on Drug Therapy; a Letter to Editor</td>\n",
       "      <td>https://doi.org/no data provided</td>\n",
       "      <td>no data providedliver and kidney injuries in covid-19 and their effects on drug therapy; a letter to editor 0.08</td>\n",
       "      <td>0.077778</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "drug use\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-22</td>\n",
       "      <td>America Addresses Two Epidemics: Cannabis and Coronavirus and their Interactions: An Ecological Geospatial Study</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.17.20069021</td>\n",
       "      <td>in interactive geospatial models adjusted for international travel, ethnicity, income, population, population density and drug use, terms including last month cannabis were significant from p=7 0.07</td>\n",
       "      <td>0.070000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-10</td>\n",
       "      <td>Pharmacy Administration and Pharmaceutical Care Practice in a Module Hospital during the COVID-19 Epidemic</td>\n",
       "      <td>https://doi.org/10.1016/j.japh.2020.04.006</td>\n",
       "      <td>this platform provided relevant pharmaceutical care for patients, such as ensuring drug supply, setting up critical care drug trolleys, designing specific drug packaging bags, creating a module radio station to broadcast rational drug use information to the patients, and other aspects 0.22 3 rmb worth of drugs (about $146,000 us dollars), reviewed about 20,000 electronic orders, provided one-on-one online medication consultation for 484 patients, and held five lectures on rational drug use knowledge, which could help reduce irrational drug use and minimize the risk involved 0.19</td>\n",
       "      <td>0.221951</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-10</td>\n",
       "      <td>Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.08.20054551</td>\n",
       "      <td>cox models were fitted to estimate calibrated hazard ratios (calhrs) according to drug use 0.24</td>\n",
       "      <td>0.242857</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-06</td>\n",
       "      <td>Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic</td>\n",
       "      <td>https://doi.org/10.1016/j.sapharm.2020.04.001</td>\n",
       "      <td>according to covid-19 prevention and control policy and requirements, combined with series of diagnosis and treatment plans, pharmacists in the first provincial-level covid-19 diagnosis and treatment unit in jilin province in northeast china have established the management practices of drug supply and pharmaceutical care from four aspects: personnel, drugs supply management, off-label drug use management and pharmaceutical care 0.15</td>\n",
       "      <td>0.151724</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-26</td>\n",
       "      <td>Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective</td>\n",
       "      <td>https://doi.org/10.1016/j.sapharm.2020.03.012</td>\n",
       "      <td>objective to discuss community pharmacists’ role and the content of pharmaceutical care (pc) during the novel coronavirus pandemic to promote effective prevention and control and safe drug use of the community patient population 0.16</td>\n",
       "      <td>0.160606</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "effective drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-20</td>\n",
       "      <td>D3Targets-2019-nCoV: a webserver for predicting drug targets and for multi-target and multi-site based virtual screening against COVID-19</td>\n",
       "      <td>https://doi.org/10.1016/j.apsb.2020.04.006</td>\n",
       "      <td>with 6 examples, we demonstrated that the webserver should be useful to medicinal chemists, pharmacologists and clinicians for efficiently discovering or developing effective drugs against the sars-cov-2 to cure covid-19 0.07</td>\n",
       "      <td>0.066667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-19</td>\n",
       "      <td>Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status</td>\n",
       "      <td>https://doi.org/10.1016/j.meegid.2020.104327</td>\n",
       "      <td>however, governments and pharmaceutical companies are struggling to quickly find an effective drug to defeat the coronavirus 0.22</td>\n",
       "      <td>0.217647</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-17</td>\n",
       "      <td>The end of the social confinement in Spain and the COVID-19 re-emergence risk</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.14.20064766</td>\n",
       "      <td>in this situation, management of a recurrent disease seems to be a plausible scenario that countries worldwide will have to face, before effective drugs or a vaccine appear 0.07</td>\n",
       "      <td>0.067857</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-16</td>\n",
       "      <td>Immunity-and-Matrix-Regulatory Cells Derived from Human Embryonic Stem Cells Safely and Effectively Treat Mouse Lung Injury and Fibrosis</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.15.042119</td>\n",
       "      <td>however, there are still no effective drugs to treat lung injury and fibrosis 0.09</td>\n",
       "      <td>0.088462</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-15</td>\n",
       "      <td>Convalescent plasma: A possible treatment of COVID-19 in India</td>\n",
       "      <td>https://doi.org/10.1016/j.mjafi.2020.04.006</td>\n",
       "      <td>there are no current effective strategies to prevent the spread, other than minimizing contact through social distancing, while no fully effective drugs to prevent or treat covid-19 exist, although several candidate drugs and repurposed antiviral and immune-modulating pharmacotherapies are being tested or in compassionate use 0.07</td>\n",
       "      <td>0.072222</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-15</td>\n",
       "      <td>Oleoylethanolamide, A Bioactive Lipid Amide, as A Promising Treatment Strategy for Coronavirus/COVID-19</td>\n",
       "      <td>https://doi.org/10.1016/j.arcmed.2020.04.006</td>\n",
       "      <td>with the emergence of the covid-19 virus and considering the lack of effective pharmaceutical treatment for it, there is an urgent need to identify safe and effective drugs or potential adjuvant therapy in this regard 0.08</td>\n",
       "      <td>0.078571</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-14</td>\n",
       "      <td>Molecular mechanism of action of repurposed drugs and traditional Chinese medicine used for the treatment of patients infected with COVID-19: A systematic review</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.10.20060376</td>\n",
       "      <td>because of the time constraints associated with the development of vaccines and effective drugs, drug repurposing and other alternative treatment methods have been used to treat patients that have been infected by the sars-cov-2 virus and have acquired covid-19 0.15</td>\n",
       "      <td>0.151282</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-12</td>\n",
       "      <td>Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.10.035824</td>\n",
       "      <td>there is an urgent call for developing effective drugs against the virus (sars-cov-2) causing this disease 0.08</td>\n",
       "      <td>0.081250</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-07</td>\n",
       "      <td>Repurposing Therapeutics for COVID-19: Rapid Prediction of Commercially available drugs through Machine Learning and Docking</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.05.20054254</td>\n",
       "      <td>among all, we suggest that the antiretroviral drug saquinavir (drugbank id db01232) would probably be one of the most effective drugs based on the selected criterions 0.18</td>\n",
       "      <td>0.176923</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-07</td>\n",
       "      <td>Prediction of COVID-19 Outbreak in China and Optimal Return Date for University Students Based on Propagation Dynamics</td>\n",
       "      <td>https://doi.org/10.1007/s12204-020-2167-2</td>\n",
       "      <td>we also discuss the impacts of some factors that may occur in the future, such as secondary infection, emergence of effective drugs, and population flow from korea to china 0.07</td>\n",
       "      <td>0.067241</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-31</td>\n",
       "      <td>Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus</td>\n",
       "      <td>https://doi.org/10.6026/97320630016236</td>\n",
       "      <td>design and development of an effective drug to combat the 2019 novel coronavirus remains a challenge 0.22</td>\n",
       "      <td>0.225000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-29</td>\n",
       "      <td>The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality</td>\n",
       "      <td>https://doi.org/10.1016/j.ijantimicag.2020.105954</td>\n",
       "      <td>so, tocilizumab is likely to become an effective drug for patients with severe covid-19 0.24</td>\n",
       "      <td>0.242857</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-16</td>\n",
       "      <td>Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2</td>\n",
       "      <td>https://doi.org/10.1038/s41421-020-0153-3</td>\n",
       "      <td>however, there are currently no effective drugs targeting 2019-ncov/sars-cov-2 0.11  drug repurposing, representing as an effective drug discovery strategy from existing drugs, could shorten the time and reduce the cost compared to de novo drug discovery 0.25</td>\n",
       "      <td>0.253846</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-12</td>\n",
       "      <td>A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.11.986836</td>\n",
       "      <td>the retrospective study using the past sars-cov and mers-cov data demonstrated that our machine learning based method can successfully predict effective drug candidates against a specific coronavirus 0.17</td>\n",
       "      <td>0.174074</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-05</td>\n",
       "      <td>Clinical trial analysis of 2019-nCoV therapy registered in China</td>\n",
       "      <td>https://doi.org/10.1002/jmv.25733</td>\n",
       "      <td>abstract so far, there is a lack of effective drugs for the new coronavirus pneumonia 0.08</td>\n",
       "      <td>0.083333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-02</td>\n",
       "      <td>Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches</td>\n",
       "      <td>https://doi.org/10.1101/2020.02.28.970343</td>\n",
       "      <td>till date, no vaccine or completely effective drug is available to cure covid-19 0.25</td>\n",
       "      <td>0.253846</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-27</td>\n",
       "      <td>Spike protein binding prediction with neutralizing antibodies of SARS-CoV-2</td>\n",
       "      <td>https://doi.org/10.1101/2020.02.22.951178</td>\n",
       "      <td>currently, researchers put their best efforts to identify effective drugs for covid-19 0.09</td>\n",
       "      <td>0.091667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-05</td>\n",
       "      <td>Network-based Drug Repurposing for Human Coronavirus</td>\n",
       "      <td>https://doi.org/10.1101/2020.02.03.20020263</td>\n",
       "      <td>drug repurposing, represented as an effective drug discovery strategy from existing drugs, could shorten the time and reduce the cost compared to de novo drug discovery 0.25</td>\n",
       "      <td>0.253846</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-04</td>\n",
       "      <td>Machine intelligence design of 2019-nCoV drugs</td>\n",
       "      <td>https://doi.org/10.1101/2020.01.30.927889</td>\n",
       "      <td>however, the viral protease of a coronavirus is well-known to be essential for its replication and thus is an effective drug target 0.19</td>\n",
       "      <td>0.190909</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020</td>\n",
       "      <td>The novel coronavirus outbreak in Wuhan, China</td>\n",
       "      <td>https://doi.org/10.1186/s41256-020-00135-6</td>\n",
       "      <td>challenges such as lacking effective drugs, insufficient hospital services and medical supplies, logistics, etc 0.09</td>\n",
       "      <td>0.085714</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020</td>\n",
       "      <td>Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province</td>\n",
       "      <td>https://doi.org/10.1097/cm9.0000000000000744</td>\n",
       "      <td>given the lack of effective drugs, treatment focused on symptomatic and respiratory support 0.09</td>\n",
       "      <td>0.088462</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "efficacious drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-22</td>\n",
       "      <td>Can pioglitazone be potentially useful therapeutically in treating patients with covid-19?</td>\n",
       "      <td>https://doi.org/10.1016/j.mehy.2020.109776</td>\n",
       "      <td>despite the immense and ongoing global effort, no efficacious drugs to fight this plague have been identified and patients admitted to the intensive care units (icu), for respiratory distress, are managed mostly by means of supportive care based on oxygen maintenance 0.06</td>\n",
       "      <td>0.062195</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "existing drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-22</td>\n",
       "      <td>Current status of potential therapeutic candidates for the COVID-19 crisis</td>\n",
       "      <td>https://doi.org/10.1016/j.bbi.2020.04.046</td>\n",
       "      <td>furthermore, intensive research and clinical trials are underway to assess the efficacy of existing drugs and identify potential therapeutic targets to develop new drugs for treating covid-19 0.07</td>\n",
       "      <td>0.068519</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-22</td>\n",
       "      <td>Hydroxychloroquine for the management of COVID-19: Hope or Hype? A Systematic review of the current evidence</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.16.20068205</td>\n",
       "      <td>with the vaccine approval likely more than a year away and novel drugs in early clinical trials, repurposing of existing drugs takes the center stage 0.07</td>\n",
       "      <td>0.070000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-16</td>\n",
       "      <td>Targeting potential drivers of COVID-19: Neutrophil extracellular traps</td>\n",
       "      <td>https://doi.org/10.1084/jem.20200652</td>\n",
       "      <td>if our hypothesis is correct, targeting nets directly and/or indirectly with existing drugs may reduce the clinical severity of covid-19 0.08</td>\n",
       "      <td>0.075000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-14</td>\n",
       "      <td>Human organs-on-chips as tools for repurposing approved drugs as potential influenza and COVID19 therapeutics in viral pandemics</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.13.039917</td>\n",
       "      <td>rapidly spreading viral pandemics, such as those caused by influenza and sar-cov-2 (covid19), require rapid action and the fastest way to combat this challenge is by repurposing existing drugs as anti-viral therapeutics 0.07</td>\n",
       "      <td>0.065625</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-10</td>\n",
       "      <td>The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) envelope (E) protein harbors a conserved BH3-like motif</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.09.033522</td>\n",
       "      <td>the identification of small molecules (or the repurposing of existing drugs) able to disrupt sars-cov-2 e bh3-mediated interactions might provide a targeted therapeutic approach for covid-19 treatment 0.07</td>\n",
       "      <td>0.068519</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-07</td>\n",
       "      <td>Repurposing Therapeutics for COVID-19: Rapid Prediction of Commercially available drugs through Machine Learning and Docking</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.05.20054254</td>\n",
       "      <td>the research includes the study of drugs that are already available in the market and being used for other diseases to accelerate clinical recovery, in other words repurposing of existing drugs 0.07</td>\n",
       "      <td>0.066129</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-02</td>\n",
       "      <td>deepMINE - Natural Language Processing based Automatic Literature Mining and Research Summarization for Early-Stage Comprehension in Pandemic Situations specifically for COVID-19</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.30.014555</td>\n",
       "      <td>this demands novel research on the vaccine to fight against this pandemic situation, re-purposing of the existing drugs, phylogenetic analysis to identify the origin and determine the similarity with other known viruses, etc 0.07</td>\n",
       "      <td>0.065152</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-01</td>\n",
       "      <td>The target landscape of N4-hydroxycytidine based on its chemical neighborhood</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.30.016485</td>\n",
       "      <td>the relevance for existing drugs within the same chemical space, such as remdesivir, is also discussed 0.08</td>\n",
       "      <td>0.081250</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-21</td>\n",
       "      <td>Replication of SARS-CoV-2 in human respiratory epithelium</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.20.999029</td>\n",
       "      <td>at present, it is of utmost importance to understand the virus biology and to rapidly assess the potential of existing drugs and develop new active compounds 0.07</td>\n",
       "      <td>0.069231</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-16</td>\n",
       "      <td>Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2</td>\n",
       "      <td>https://doi.org/10.1038/s41421-020-0153-3</td>\n",
       "      <td>drug repurposing, representing as an effective drug discovery strategy from existing drugs, could shorten the time and reduce the cost compared to de novo drug discovery 0.25</td>\n",
       "      <td>0.253846</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-05</td>\n",
       "      <td>Network-based Drug Repurposing for Human Coronavirus</td>\n",
       "      <td>https://doi.org/10.1101/2020.02.03.20020263</td>\n",
       "      <td>drug repurposing, represented as an effective drug discovery strategy from existing drugs, could shorten the time and reduce the cost compared to de novo drug discovery 0.25</td>\n",
       "      <td>0.253846</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020</td>\n",
       "      <td>Management and clinical thinking of Coronavirus Disease 2019</td>\n",
       "      <td>https://doi.org/10.3760/cma.j.issn.1007-3418.2020.0002</td>\n",
       "      <td>how to effectively control the spread of covid-19? when does the population infection rate rise to its peak? what will eventually be the number of infected patients? how to make early diagnosis? what effective antiviral drugs are available? how to effectively treat with existing drugs? can it successfully improve the survival rate of critically patients? in response to the above questions, we put forward corresponding suggestions and reflections from the perspective of the infectious clinician 0.06</td>\n",
       "      <td>0.056667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020</td>\n",
       "      <td>Daily briefing: The potential for repurposing existing drugs to fight COVID-19 coronavirus</td>\n",
       "      <td>https://doi.org/10.1038/d41586-020-00412-x</td>\n",
       "      <td>daily briefing: the potential for repurposing existing drugs to fight covid-19 coronavirus 0.09</td>\n",
       "      <td>0.091667</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "find drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-18</td>\n",
       "      <td>Benefits and Risks of Chloroquine and Hydroxychloroquine in The Treatment of Viral Diseases: A Meta-Analysis of Placebo Randomized Controlled Trials</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.13.20064295</td>\n",
       "      <td>background and objective: recently, in the scramble to find drugs to treat covid-19, chloroquine (cq) and its derivative hydroxychloroquine (hcq) have rapidly gained the public attention 0.07</td>\n",
       "      <td>0.069231</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "gold drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-15</td>\n",
       "      <td>The FDA-approved gold drug Auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.14.041228</td>\n",
       "      <td>herein, we report that the fda-approved gold drug, auranofin, inhibits sars-cov-2 replication in human cells at low micro molar concentration 0.08 the fda-approved gold drug auranofin inhibits novel coronavirus (sars-cov-2) replication and attenuates inflammation in human cells 0.22</td>\n",
       "      <td>0.225</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "hiv drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-02-04</td>\n",
       "      <td>Machine intelligence design of 2019-nCoV drugs</td>\n",
       "      <td>https://doi.org/10.1101/2020.01.30.927889</td>\n",
       "      <td>the potential effectiveness of treating 2019-ncov by using some existing hiv drugs is also analyzed 0.08</td>\n",
       "      <td>0.083333</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "including drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-01</td>\n",
       "      <td>The target landscape of N4-hydroxycytidine based on its chemical neighborhood</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.30.016485</td>\n",
       "      <td>to join worldwide efforts in identifying potential drug targets against this pandemic, the target landscape of nhc was defined by extracting all known targets of its chemical neighborhood, including drugs, analogues, and metabolites, and by performing target predictions from two independent platforms, following the recent public health assessment via structural evaluation (phase) protocol 0.14</td>\n",
       "      <td>0.137736</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-30</td>\n",
       "      <td>Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model</td>\n",
       "      <td>https://doi.org/10.1016/j.csbj.2020.03.025</td>\n",
       "      <td>due to the lack of effective treatment options for sars-cov-2, various strategies are being tested in china, including drug repurposing 0.2</td>\n",
       "      <td>0.200000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-02</td>\n",
       "      <td>Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China through a drug-target interaction deep learning model</td>\n",
       "      <td>https://doi.org/10.1101/2020.01.31.929547</td>\n",
       "      <td>due to the lack of effective treatment options for 2019-ncov, various strategies are being tested in china, including drug repurposing 0.2</td>\n",
       "      <td>0.200000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "inhalable drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-18</td>\n",
       "      <td>Synthetic nanobodies targeting the SARS-CoV-2 receptor-binding domain</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.16.045419</td>\n",
       "      <td>it is anticipated that compact binders such as these sybodies could feasibly be developed into an inhalable drug that can be used as a convenient prophylaxis against covid-19 0.17</td>\n",
       "      <td>0.171429</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "inhibitory drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-18</td>\n",
       "      <td>Investigating the genomic landscape in novel coronavirus (2019-nCoV) genomes to identify non-synonymous mutations for use in diagnosis and drug design</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.16.043273</td>\n",
       "      <td>all efforts to contain the pathogenesis either using inhibitory drugs or vaccines largely remained futile due to a lack of better understanding of the genomic feature of this virus 0.07  this analysis will provide an explanation for varying treatment efficacies of different inhibitory drugs and a future direction towards a combinatorial treatment therapies based on the kind of mutation in the viral genome 0.07</td>\n",
       "      <td>0.067241</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "narcotic drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020</td>\n",
       "      <td>Anesthesia management for cesarean section during novel coronavirous epidemic</td>\n",
       "      <td>https://doi.org/no data provided</td>\n",
       "      <td>narcotic drugs were used for one patient only, and disposable medical supplies were used for anesthetic supplies 0.08</td>\n",
       "      <td>0.079412</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "new drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-22</td>\n",
       "      <td>Current status of potential therapeutic candidates for the COVID-19 crisis</td>\n",
       "      <td>https://doi.org/10.1016/j.bbi.2020.04.046</td>\n",
       "      <td>furthermore, intensive research and clinical trials are underway to assess the efficacy of existing drugs and identify potential therapeutic targets to develop new drugs for treating covid-19 0.07</td>\n",
       "      <td>0.068519</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-22</td>\n",
       "      <td>SARS-CoV-2 and COVID-19: What are our options? Where should we focus our attention on to find new drugs and strategies?</td>\n",
       "      <td>https://doi.org/10.1016/j.tmaid.2020.101685</td>\n",
       "      <td>no data providedsars-cov-2 and covid-19: what are our options? where should we focus our attention on to find new drugs and strategies? 0.07</td>\n",
       "      <td>0.072727</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-20</td>\n",
       "      <td>Identification and enrichment of SECReTE cis-acting RNA elements in the Coronaviridae and other (+) single-strand RNA viruses</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.20.050088</td>\n",
       "      <td>future studies of secrete function and identification of secrete-binding proteins could provide new drug targets to treat covid-19 and other (+)ssrna related diseases 0.19</td>\n",
       "      <td>0.186957</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-09</td>\n",
       "      <td>Robust neutralization assay based on SARS-CoV-2 S-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressed BHK21 cells</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.08.026948</td>\n",
       "      <td>this efficient and reliable pseudovirus assay model could facilitate the development of new drugs and vaccines 0.08</td>\n",
       "      <td>0.081250</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-07</td>\n",
       "      <td>Repurposing Therapeutics for COVID-19: Rapid Prediction of Commercially available drugs through Machine Learning and Docking</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.05.20054254</td>\n",
       "      <td>the vast complexity in drug design and protocols regarding clinical trials often prohibit developing various new drug combinations for this epidemic disease in a limited time 0.22</td>\n",
       "      <td>0.215385</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-04</td>\n",
       "      <td>In-silico analysis of SARS-CoV-2 genomes: Insights from SARS encoded non-coding RNAs</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.31.018499</td>\n",
       "      <td>the study provides insights into the overlapping sequences among these viruses for their effective inhibition as well as identifying new drug targets that could be used for development of new antivirals 0.2</td>\n",
       "      <td>0.196774</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-03</td>\n",
       "      <td>Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study</td>\n",
       "      <td>https://doi.org/10.1016/s0140-6736(20)30566-3</td>\n",
       "      <td>funding chinese academy of medical sciences innovation fund for medical sciences; national science grant for distinguished young scholars; national key research and development program of china; the beijing science and technology project; and major projects of national science and technology on new drug creation and development 0.14</td>\n",
       "      <td>0.143478</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-25</td>\n",
       "      <td>Drug repurposing strategies for COVID-19</td>\n",
       "      <td>https://doi.org/10.4155/fdd-2020-0010</td>\n",
       "      <td>developing new drugs from scratch is a lengthy process, thus impractical to face the immediate global challenge 0.08</td>\n",
       "      <td>0.079412</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-18</td>\n",
       "      <td>A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19</td>\n",
       "      <td>https://doi.org/10.1056/nejmoa2001282</td>\n",
       "      <td>(funded by major projects of national science and technology on new drug creation and development and others; chinese clinical trial register number, chictr2000029308 0.19</td>\n",
       "      <td>0.186957</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-05</td>\n",
       "      <td>Clinical trial analysis of 2019-nCoV therapy registered in China</td>\n",
       "      <td>https://doi.org/10.1002/jmv.25733</td>\n",
       "      <td>compared with that of during sars period in 2003, china have the stronger capability to carry out clinical trials of new drugs in emergency period 0.07</td>\n",
       "      <td>0.070000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-05</td>\n",
       "      <td>Targeted Oxidation Strategy (TOS) for Potential Inhibition of Coronaviruses by Disulfiram — a 70-Year Old Anti-Alcoholism Drug</td>\n",
       "      <td>https://doi.org/10.26434/chemrxiv.11936292.v1</td>\n",
       "      <td>the pandemic of 2019-ncov reminds us of the urgency to search new drugs with totally different mechanism that may target the weaknesses specific to coronaviruses 0.07</td>\n",
       "      <td>0.070000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-02</td>\n",
       "      <td>Predictions for the binding domain and potential new drug targets of 2019-nCoV</td>\n",
       "      <td>https://doi.org/10.1101/2020.02.26.961938</td>\n",
       "      <td>the current state of the epidemic is increasingly serious, and there has been the urgent necessity to develop an effective new drug 0.19 predictions for the binding domain and potential new drug targets of 2019-ncov 0.27</td>\n",
       "      <td>0.266667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-27</td>\n",
       "      <td>Structure of Mpro from COVID-19 virus and discovery of its inhibitors</td>\n",
       "      <td>https://doi.org/10.1101/2020.02.26.964882</td>\n",
       "      <td>in order to rapidly discover lead compounds for clinical use, we initiated a program of combined structure-assisted drug design, virtual drug screening and high-throughput screening to identify new drug leads that target the covid-19 virus main protease (mpro) 0.21</td>\n",
       "      <td>0.205263</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020</td>\n",
       "      <td>Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods</td>\n",
       "      <td>https://doi.org/10.1016/j.apsb.2020.02.008</td>\n",
       "      <td>because of time consuming process of new drug development, drug repositioning may be the only solution to the epidemic of sudden infectious diseases 0.23</td>\n",
       "      <td>0.230435</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "novel drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-22</td>\n",
       "      <td>Hydroxychloroquine for the management of COVID-19: Hope or Hype? A Systematic review of the current evidence</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.16.20068205</td>\n",
       "      <td>with the vaccine approval likely more than a year away and novel drugs in early clinical trials, repurposing of existing drugs takes the center stage 0.07</td>\n",
       "      <td>0.070000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-17</td>\n",
       "      <td>Recapitulation of SARS-CoV-2 Infection and Cholangiocyte Damage with Human Liver Organoids</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.16.990317</td>\n",
       "      <td>our findings also provide an application of human organoids in investigating the tropism and pathogenesis of sars-cov-2, which would facilitate novel drug discovery 0.19</td>\n",
       "      <td>0.186957</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-11</td>\n",
       "      <td>Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds</td>\n",
       "      <td>https://doi.org/10.1002/minf.202000028</td>\n",
       "      <td>along these efforts, the structure of sars-cov-2 main protease (mpro) has been rapidly resolved and made publicly available to facilitate global efforts to develop novel drug candidates 0.17</td>\n",
       "      <td>0.174074</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-02</td>\n",
       "      <td>Predictions for the binding domain and potential new drug targets of 2019-nCoV</td>\n",
       "      <td>https://doi.org/10.1101/2020.02.26.961938</td>\n",
       "      <td>furthermore, site prediction on the surface glycoprotein of 2019-ncov suggests some core amino acid area may be a novel drug target against 2019-ncov 0.19</td>\n",
       "      <td>0.186957</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "potential drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-22</td>\n",
       "      <td>Hydroxychloroquine for the management of COVID-19: Hope or Hype? A Systematic review of the current evidence</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.16.20068205</td>\n",
       "      <td>a potential drug discussed both in geopolitical and global scientific community is hydroxychloroquine (hcq) 0.24</td>\n",
       "      <td>0.242857</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-22</td>\n",
       "      <td>Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance</td>\n",
       "      <td>https://doi.org/10.1016/j.nmni.2020.100684</td>\n",
       "      <td>towards that initiative, potential drugs like hydroxychloroquine, ivermectin and azithromycin have been tested by diverse group of researchers worldwide for their potential against novel coronavirus 0.09</td>\n",
       "      <td>0.090000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-20</td>\n",
       "      <td>D3Targets-2019-nCoV: a webserver for predicting drug targets and for multi-target and multi-site based virtual screening against COVID-19</td>\n",
       "      <td>https://doi.org/10.1016/j.apsb.2020.04.006</td>\n",
       "      <td>for the purpose, we developed a molecular docking based webserver, namely d3targets-2019-ncov, with two functions, one is for predicting drug targets for drugs or active compounds observed from clinic or in vitro/in vivo studies, the other is for identifying lead compounds against potential drug targets via docking 0.16</td>\n",
       "      <td>0.163830</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-18</td>\n",
       "      <td>An in silico map of the SARS-CoV-2 RNA Structurome</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.17.045161</td>\n",
       "      <td>our results find that the sars-cov-2 is greatly enriched in unusually stable and likely evolutionarily ordered rna structure, which provides a huge reservoir of potential drug targets for rna-binding small molecules 0.16</td>\n",
       "      <td>0.164516</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-18</td>\n",
       "      <td>Potential microenvironment of SARS-CoV-2 infection in airway epithelial cells revealed by Human Protein Atlas database analysis</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.16.045799</td>\n",
       "      <td>our findings provide a new research direction for understanding the potential microenvironment required by sars-cov-2 infection in airway epithelial, which may assist in the discovery of potential drug targets against sars-cov-2 infection 0.19</td>\n",
       "      <td>0.193750</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-15</td>\n",
       "      <td>TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.15.042085</td>\n",
       "      <td>in order for sars-cov-2 to enter cells, its surface glycoprotein spike (s) must be cleaved at two different sites by host cell proteases, which therefore represent potential drug targets 0.17</td>\n",
       "      <td>0.168966</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-15</td>\n",
       "      <td>Phylogenetic Analysis of the Novel Coronavirus Reveals Important Variants in Indian Strains</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.14.041301</td>\n",
       "      <td>its important to observe the changes in nsp3 gene, as this gene has been reported with extensive positive selection as well as potential drug target 0.18</td>\n",
       "      <td>0.180000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-14</td>\n",
       "      <td>Repurposing Didanosine as a Potential Treatment for COVID-19 Using Single-Cell RNA Sequencing Data</td>\n",
       "      <td>https://doi.org/10.1128/msystems.00297-20</td>\n",
       "      <td>there is no approved drug or vaccine for covid-19, although more than 10 clinical trials have been launched to test potential drugs 0.19</td>\n",
       "      <td>0.190909</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-01</td>\n",
       "      <td>The target landscape of N4-hydroxycytidine based on its chemical neighborhood</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.30.016485</td>\n",
       "      <td>to join worldwide efforts in identifying potential drug targets against this pandemic, the target landscape of nhc was defined by extracting all known targets of its chemical neighborhood, including drugs, analogues, and metabolites, and by performing target predictions from two independent platforms, following the recent public health assessment via structural evaluation (phase) protocol 0.14</td>\n",
       "      <td>0.137736</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-31</td>\n",
       "      <td>The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future</td>\n",
       "      <td>https://doi.org/10.1016/j.micinf.2020.02.002</td>\n",
       "      <td>intensive research on the novel emerging human infectious coronaviruses is urgently needed to elucidate their route of transmission and pathogenic mechanisms, and to identify potential drug targets, which would promote the development of effective preventive and therapeutic countermeasures 0.15</td>\n",
       "      <td>0.152632</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-30</td>\n",
       "      <td>Genetic Profiles in Pharmacogenes Indicate Personalized Drug Therapy for COVID-19</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.23.20041350</td>\n",
       "      <td>methods: we selected 67 potential drugs for covid-19 therapy (dcts) from clinical guideline and clinical trials databases 0.08  224 potential drug-drug interactions (ddi) of dcts were predicted, while 112 of them have been reported 0.08</td>\n",
       "      <td>0.081250</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-29</td>\n",
       "      <td>Coronavirus disease 2019 (COVID-19): current status and future perspectives</td>\n",
       "      <td>https://doi.org/10.1016/j.ijantimicag.2020.105951</td>\n",
       "      <td>intensive research on the newly emerged sars-cov-2 is urgently needed to elucidate the pathogenic mechanisms and epidemiological characteristics and to identify potential drug targets, which will contribute to the development of effective prevention and treatment strategies 0.16</td>\n",
       "      <td>0.155556</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-24</td>\n",
       "      <td>A unifying structural and functional model of the coronavirus replication organelle: tracking down RNA synthesis</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.24.005298</td>\n",
       "      <td>our results provide a unifying model of the cov ro and clearly establish dmvs as the central hub for viral rna synthesis and a potential drug target in coronavirus infection 0.17</td>\n",
       "      <td>0.166667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-23</td>\n",
       "      <td>Effectiveness and safety of antiviral or antibody treatments for coronavirus</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.19.20039008</td>\n",
       "      <td>eighteen studies reported potential drug-related adverse effects including gastrointestinal symptoms, anemia, and altered liver function in patients receiving ribavirin 0.08</td>\n",
       "      <td>0.076316</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-22</td>\n",
       "      <td>A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.22.002386</td>\n",
       "      <td>a sars-cov-2-human protein-protein interaction map reveals drug targets and potential drug-repurposing 0.28</td>\n",
       "      <td>0.281818</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-16</td>\n",
       "      <td>Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2</td>\n",
       "      <td>https://doi.org/10.1038/s41421-020-0153-3</td>\n",
       "      <td>in summary, this study offers powerful network-based methodologies for rapid identification of candidate repurposable drugs and potential drug combinations targeting 2019-ncov/sars-cov-2 0.2</td>\n",
       "      <td>0.195238</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-12</td>\n",
       "      <td>A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.11.986836</td>\n",
       "      <td>we developed a data-driven drug repositioning framework, which applies both machine learning and statistical analysis approaches to systematically integrate and mine large-scale knowledge graph, literature and transcriptome data to discover the potential drug candidates against sars-cov-2 0.18</td>\n",
       "      <td>0.183333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-06</td>\n",
       "      <td>Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model</td>\n",
       "      <td>https://doi.org/10.1097/cm9.0000000000000797</td>\n",
       "      <td>the anti-viral activities and anti-viral mechanisms of potential drugs were further investigated 0.09  cep, selamectin, and mefloquine hydrochloride are potential drugs for treating 2019-ncov infection 0.09</td>\n",
       "      <td>0.091667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-25</td>\n",
       "      <td>Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV</td>\n",
       "      <td>https://doi.org/10.1002/cbic.202000047</td>\n",
       "      <td>herein, we suggest four potential drug candidates (an ace2‐based peptide, remdesivir, 3clpro‐1 and a novel vinylsulfone protease inhibitor) that could be used to treat patients suffering with the 2019‐ncov 0.17</td>\n",
       "      <td>0.168966</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-10</td>\n",
       "      <td>Artificial intelligence finds drugs that could fight the new coronavirus</td>\n",
       "      <td>https://doi.org/10.1021/cen-09806-scicon1</td>\n",
       "      <td>benevolentai’s algorithms connect molecular structure data to biomedical information about relevant receptors and diseases to find potential drug targets 0.21</td>\n",
       "      <td>0.205263</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-05</td>\n",
       "      <td>Network-based Drug Repurposing for Human Coronavirus</td>\n",
       "      <td>https://doi.org/10.1101/2020.02.03.20020263</td>\n",
       "      <td>finally, we showcased three potential drug combinations (including sirolimus plus dactinomycin, mercaptopurine plus melatonin, and toremifene plus emodin) captured by the complementary exposure pattern: the targets of the drugs both hit the hcov-host subnetwork, but target separate neighborhoods in the human protein-protein interactome network 0.15  in summary, this study offers powerful network-based methodologies for rapid identification of candidate repurposable drugs and potential drug combinations toward future clinical trials for hcovs 0.18</td>\n",
       "      <td>0.180000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020</td>\n",
       "      <td>Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods</td>\n",
       "      <td>https://doi.org/10.1016/j.apsb.2020.02.008</td>\n",
       "      <td>possible targets of these compounds and potential drugs acting on a certain target were predicted 0.08 analysis of therapeutic targets for sars-cov-2 and discovery of potential drugs by computational methods 0.09</td>\n",
       "      <td>0.085714</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "promising drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-20</td>\n",
       "      <td>Therapeutic strategies for critically ill patients with COVID-19</td>\n",
       "      <td>https://doi.org/10.1186/s13613-020-00661-z</td>\n",
       "      <td>in the present article, we have summarized the promising drugs, adjunctive agents, respiratory supportive strategies, as well as circulation management, multiple organ function monitoring and appropriate nutritional strategies for the treatment of covid-19 in the icu based on the previous experience of treating other viral infections and influenza 0.06</td>\n",
       "      <td>0.060417</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-15</td>\n",
       "      <td>TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.15.042085</td>\n",
       "      <td>our data demonstrate that both tmprss2 and furin are essential for sars-cov-2 activation in human airway cells and are promising drug targets for the treatment of covid-19 either by targeting one of these proteases alone or by a combination of furin and tmprss2 inhibitors 0.15 tmprss2 and furin are both essential for proteolytic activation and spread of sars-cov-2 in human airway epithelial cells and provide promising drug targets 0.19</td>\n",
       "      <td>0.186957</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-11</td>\n",
       "      <td>In-depth Bioinformatic Analyses of Human SARS-CoV-2, SARS-CoV, MERS-CoV, and Other Nidovirales Suggest Important Roles of Noncanonical Nucleic Acid Structures in Their Lifecycles</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.09.031252</td>\n",
       "      <td>noncanonical nucleic acids structures in nidovirales and in novel sars-cov-2 are therefore promising druggable structures that can be targeted and utilized in the future 0.07</td>\n",
       "      <td>0.070833</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-28</td>\n",
       "      <td>Structure-Based Design, Synthesis and Biological Evaluation of Peptidomimetic Aldehydes as a Novel Series of Antiviral Drug Candidates Targeting the SARS-CoV-2 Main Protease</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.25.996348</td>\n",
       "      <td>both compounds are promising drug leads with clinical potential that merits further studies 0.25</td>\n",
       "      <td>0.253846</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-03</td>\n",
       "      <td>Systematic Review of the Registered Clinical Trials of Coronavirus Disease 2019 (COVID-19)</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.01.20029611</td>\n",
       "      <td>improving the quality of study design, prioritizing promising drugs, and using different designs and statistical methods are worth advocating and recommending for the clinical trials of covid-19 in china 0.07</td>\n",
       "      <td>0.067241</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "proven drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-03-26</td>\n",
       "      <td>Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants †</td>\n",
       "      <td>https://doi.org/10.1016/j.jpha.2020.03.009</td>\n",
       "      <td>3clpro is a proven drug discovery target in the case of severe acute respiratory syndrome coronavirus (sars-cov) and middle east respiratory syndrome coronavirus (mers-cov) 0.18</td>\n",
       "      <td>0.183333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-03</td>\n",
       "      <td>Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.02.968388</td>\n",
       "      <td>there is no existing vaccine or proven drug to prevent infections and stop virus proliferation 0.23</td>\n",
       "      <td>0.233333</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "purchasable drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-02-21</td>\n",
       "      <td>Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL (pro)) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates</td>\n",
       "      <td>https://doi.org/10.12688/f1000research.22457.1</td>\n",
       "      <td>with the 3cl (pro) molecular model, we performed virtual screening for purchasable drugs and proposed 16 candidates for consideration 0.08</td>\n",
       "      <td>0.076316</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020</td>\n",
       "      <td>Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CLpro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates</td>\n",
       "      <td>https://doi.org/no data provided</td>\n",
       "      <td>with the 3clpro molecular model, we performed virtual screening for purchasable drugs and proposed 16 candidates for consideration 0.08</td>\n",
       "      <td>0.077778</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "repurposed drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-14</td>\n",
       "      <td>Molecular mechanism of action of repurposed drugs and traditional Chinese medicine used for the treatment of patients infected with COVID-19: A systematic review</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.10.20060376</td>\n",
       "      <td>in this systematic review, we provide an overview of the molecular mechanism of action of repurposed drugs or alternative treatment medicines used to attenuate covid-19 disease 0.07 molecular mechanism of action of repurposed drugs and traditional chinese medicine used for the treatment of patients infected with covid-19: a systematic review 0.07</td>\n",
       "      <td>0.071739</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-09</td>\n",
       "      <td>Reversal of Infected Host Gene Expression Identifies Repurposed Drug Candidates for COVID-19</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.07.030734</td>\n",
       "      <td>reversal of infected host gene expression identifies repurposed drug candidates for covid-19 0.27</td>\n",
       "      <td>0.266667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-05</td>\n",
       "      <td>Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.04.020925</td>\n",
       "      <td>together, our data strongly suggest that atv and atv/rtv should be considered among the candidate repurposed drugs undergoing clinical trials in the fight against covid-19 0.07</td>\n",
       "      <td>0.070000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-25</td>\n",
       "      <td>Drug repurposing strategies for COVID-19</td>\n",
       "      <td>https://doi.org/10.4155/fdd-2020-0010</td>\n",
       "      <td>while using such repurposed drugs individually may ultimately not yield a significant clinical benefit, carefully combined cocktails could be very effective, as was for hiv in the 1990s; the urgent question now being which combination 0.06</td>\n",
       "      <td>0.064286</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-13</td>\n",
       "      <td>The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status</td>\n",
       "      <td>https://doi.org/10.1186/s40779-020-00240-0</td>\n",
       "      <td>currently, there are few specific antiviral strategies, but several potent candidates of antivirals and repurposed drugs are under urgent investigation 0.08</td>\n",
       "      <td>0.075000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020</td>\n",
       "      <td>In the pipeline Derek Lowe's commentary on drug discovery and the pharma industry. An editorially independent blog from the publishers of Science Translational Medicine. All content is Derek’s own, and he does not in any way speak for his employer</td>\n",
       "      <td>https://doi.org/no data provided</td>\n",
       "      <td>the ones at the front of the line are repurposed drugs that are already approved for human use, for a lot of obvious reasons 0.07</td>\n",
       "      <td>0.070833</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "several drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-17</td>\n",
       "      <td>Can post-exposure prophylaxis for COVID-19 be considered as one of outbreak response strategies in long-term care hospitals?</td>\n",
       "      <td>https://doi.org/10.1016/j.ijantimicag.2020.105988</td>\n",
       "      <td>although several drugs have been proposed as treatment regimens, there are no data on the effectiveness and safety of post-exposure prophylaxis (pep) for covid-19 0.07</td>\n",
       "      <td>0.070833</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-05</td>\n",
       "      <td>In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.03.023846</td>\n",
       "      <td>several drugs, such as azithromycine, opipramol, quinidine or omeprazol present antiviral potency with 2<ec50<20µm 0.09</td>\n",
       "      <td>0.085714</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-29</td>\n",
       "      <td>Discovering drugs to treat coronavirus disease 2019 (COVID-19)</td>\n",
       "      <td>https://doi.org/10.5582/ddt.2020.01012</td>\n",
       "      <td>several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of coronavirus disease 2019 (covid-19) in china; some promising results have been achieved thus far 0.06</td>\n",
       "      <td>0.063158</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "specific drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-30</td>\n",
       "      <td>Coronavirus 2019-nCoV: A brief perspective from the front line</td>\n",
       "      <td>https://doi.org/10.1016/j.jinf.2020.02.010</td>\n",
       "      <td>at present, there is no vaccine or specific drugs for the human coronavirus 0.09</td>\n",
       "      <td>0.088462</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-22</td>\n",
       "      <td>Les professionnels de santé face à la pandémie de la maladie à coronavirus (COVID-19): quels risques pour leur santé mentale?</td>\n",
       "      <td>https://doi.org/10.1016/j.encep.2020.04.008</td>\n",
       "      <td>stress may also be caused by organizational factors, such as depletion of personal protection equipment, concern about not being able to provide competent care if deployed to new area, concern about rapidly changing information, lack of access to up-to-date information and communication, lack of specific drugs, the shortage of ventilators and intensive care unit beds necessary to care for the surge of critically ill patients, and significant change in their daily social and family life 0.06</td>\n",
       "      <td>0.056667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-22</td>\n",
       "      <td>The important role of polysaccharides from a traditional Chinese medicine-Lung Cleansing and Detoxifying Decoction against the COVID-19 pandemic</td>\n",
       "      <td>https://doi.org/10.1016/j.carbpol.2020.116346</td>\n",
       "      <td>there are currently no specific drugs to prevent the reproduction and spread of covid-19 0.09</td>\n",
       "      <td>0.085714</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-20</td>\n",
       "      <td>Therapeutic strategies for critically ill patients with COVID-19</td>\n",
       "      <td>https://doi.org/10.1186/s13613-020-00661-z</td>\n",
       "      <td>these treatments are referable before the vaccine and specific drugs are available for covid-19 0.09</td>\n",
       "      <td>0.085714</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-15</td>\n",
       "      <td>Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor</td>\n",
       "      <td>https://doi.org/10.1021/acsnano.0c02823</td>\n",
       "      <td>because no specific drugs or vaccines for covid-19 are yet available, early diagnosis and management are crucial for containing the outbreak 0.07</td>\n",
       "      <td>0.073810</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-15</td>\n",
       "      <td>Analysis of SARS-CoV-2-controlled autophagy reveals spermidine, MK-2206, and niclosamide as putative antiviral therapeutics</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.15.997254</td>\n",
       "      <td>abstractsevere acute respiratory syndrome coronavirus 2 (sars-cov-2) poses an acute threat to public health and the world economy, especially because no approved specific drugs or vaccines are available 0.07</td>\n",
       "      <td>0.067857</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-10</td>\n",
       "      <td>Pharmacy Administration and Pharmaceutical Care Practice in a Module Hospital during the COVID-19 Epidemic</td>\n",
       "      <td>https://doi.org/10.1016/j.japh.2020.04.006</td>\n",
       "      <td>this platform provided relevant pharmaceutical care for patients, such as ensuring drug supply, setting up critical care drug trolleys, designing specific drug packaging bags, creating a module radio station to broadcast rational drug use information to the patients, and other aspects 0.22</td>\n",
       "      <td>0.221951</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-31</td>\n",
       "      <td>Target Virus or Target Ourselves for COVID-19 Drugs Discovery?-Lessons learned from anti-influenzas virus therapies</td>\n",
       "      <td>https://doi.org/10.1016/j.medidd.2020.100037</td>\n",
       "      <td>currently, there is no vaccine or specific drug to treat covid-19, which is caused by a novel coronavirus, sars-2-cov 0.21</td>\n",
       "      <td>0.205263</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-25</td>\n",
       "      <td>FEP-based screening prompts drug repositioning against COVID-19</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.23.004580</td>\n",
       "      <td>there are no specific drugs or vaccines against covid-19, thus effective antiviral agents are still urgently needed to combat this virus 0.07</td>\n",
       "      <td>0.073810</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-23</td>\n",
       "      <td>Climatic influences on the worldwide spread of SARS-CoV-2</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.19.20038158</td>\n",
       "      <td>given the lack of both specific drugs and an efficient preventive vaccine, the expectation that the sars-cov-2 transmission rate might decrease in temperate regions during summer, dominated in the social scene 0.07</td>\n",
       "      <td>0.066129</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-16</td>\n",
       "      <td>Transmission dynamics of the COVID-19 outbreak and effectiveness of government interventions: A data-driven analysis</td>\n",
       "      <td>https://doi.org/10.1002/jmv.25750</td>\n",
       "      <td>isolation and protective procedures would be less effective as more cases accrue, so the optimization of treatment plan and the development of specific drugs would be of more importance 0.07</td>\n",
       "      <td>0.067241</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-11</td>\n",
       "      <td>Drug targets for corona virus: A systematic review</td>\n",
       "      <td>https://doi.org/10.4103/ijp.ijp_115_20</td>\n",
       "      <td>however, the lack of specific drugs to prevent/treat an attack is a major need at this current point of time 0.08</td>\n",
       "      <td>0.075000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-09</td>\n",
       "      <td>Mesenchymal Stem Cell Infusion Shows Promise for Combating Coronavirus (COVID-19)- Induced Pneumonia</td>\n",
       "      <td>https://doi.org/10.14336/ad.2020.0301</td>\n",
       "      <td>currently, treating covid-19 patients, particularly those afflicted with severe pneumonia, is challenging as no specific drugs or vaccines against sars-cov-2 are available 0.07</td>\n",
       "      <td>0.072727</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-03</td>\n",
       "      <td>Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 687 Million Compounds</td>\n",
       "      <td>https://doi.org/10.26434/chemrxiv.11923239.v1</td>\n",
       "      <td>to this date, no specific drugs or vaccines are available to treat sars-cov-2 despite its close relation to the sars-cov-1 virus that caused a similar epidemic in 2003 0.07</td>\n",
       "      <td>0.067857</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-27</td>\n",
       "      <td>Structure of Mpro from COVID-19 virus and discovery of its inhibitors</td>\n",
       "      <td>https://doi.org/10.1101/2020.02.26.964882</td>\n",
       "      <td>our results demonstrate the efficacy of this screening strategy, which can lead to the rapid discovery of drug leads with clinical potential in response to new infectious diseases where no specific drugs or vaccines are available 0.16</td>\n",
       "      <td>0.155556</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020</td>\n",
       "      <td>Strategies for the development of drugs targeting novel coronavirus 2019-nCoV</td>\n",
       "      <td>https://doi.org/no data provided</td>\n",
       "      <td>&lt;p&gt;&lt;b&gt;&lt;/b&gt; there is no specific drug that has been approved for 2019-ncov 0.27</td>\n",
       "      <td>0.266667</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "structural drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-21</td>\n",
       "      <td>Bioinformatics Study on Structural Protein of Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) For Better Understanding the Vaccine Development</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.21.053199</td>\n",
       "      <td>this fairly simple method may help us understand how antivirals and vaccines could be produced against it such models are the starting point of the community for structural drug and vaccine designs as well as virtual computational screening 0.15</td>\n",
       "      <td>0.152632</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "therapeutic drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-04-18</td>\n",
       "      <td>Preliminary therapeutic drug monitoring data of β-lactams in critically ill patients with SARS-CoV-2 infection</td>\n",
       "      <td>https://doi.org/10.1016/j.accpm.2020.04.005</td>\n",
       "      <td>no data providedpreliminary therapeutic drug monitoring data of β-lactams in critically ill patients with sars-cov-2 infection 0.22</td>\n",
       "      <td>0.225000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-17</td>\n",
       "      <td>Chloroquine paradox may cause more damage than help fight COVID-19</td>\n",
       "      <td>https://doi.org/10.1016/j.micinf.2020.04.004</td>\n",
       "      <td>abstract novel coronavirus disease 2019 (covid-19) pandemic is the most recent health care crisis without specific prophylactic or therapeutic drugs 0.08</td>\n",
       "      <td>0.075000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-15</td>\n",
       "      <td>Pharmacotherapy in COVID-19; A narrative review for emergency providers</td>\n",
       "      <td>https://doi.org/10.1016/j.ajem.2020.04.035</td>\n",
       "      <td>discussion there are currently no therapeutic drugs available that are directly active against sars-cov-2; however, several antivirals (remdesivir, favipiravir) and antimalarials (chloroquine, hydroxychloroquine) have emerged as potential therapies 0.07</td>\n",
       "      <td>0.067857</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-14</td>\n",
       "      <td>Pulmonary radiological change of COVID-19 patients with 99mTc-MDP treatment</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.07.20054767</td>\n",
       "      <td>background: as increasing cases of covid-19 around world, urgent need for effective covid-19-specific therapeutic drugs is necessary; therefore, we conducted a pilot randomized-controlled study to evaluate the efficacy of 99mtc-mdp for covid-19 therapeutic treatment 0.08</td>\n",
       "      <td>0.079412</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-11</td>\n",
       "      <td>COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles’ heel conserved region to minimize probability of escape mutations and drug resistance</td>\n",
       "      <td>https://doi.org/10.1016/j.compbiomed.2020.103749</td>\n",
       "      <td>covid-19 coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles’ heel conserved region to minimize probability of escape mutations and drug resistance 0.16</td>\n",
       "      <td>0.162500</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-01</td>\n",
       "      <td>The potential of low molecular weight heparin to mitigate cytokine storm in severe covid-19 patients: a retrospective clinical study</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.28.20046144</td>\n",
       "      <td>effective therapeutic drugs are urgently needed to improve the overall prognosis of patients, but currently no such drugs are available 0.08  interpretation in this study, we found that lmwh can improve the coagulation dysfunction of covid-19 patients, and has anti-inflammatory effects of reducing il-6 and increasing lymphocyte%, which can be used as a potential therapeutic drug for the treatment of covid-19 and provide guidance for subsequent clinical treatment 0.14</td>\n",
       "      <td>0.142553</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-31</td>\n",
       "      <td>Epidemiology, genome and clinical features of the pandemic SARS-CoV-2: a recent view</td>\n",
       "      <td>https://doi.org/10.1016/j.nmni.2020.100672</td>\n",
       "      <td>unfortunately, no effective treatment or therapeutic drug is available for the disease; only supportive treatment and classical intervention measures are available for confronting the sars-cov-2 pandemic 0.18</td>\n",
       "      <td>0.176923</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-29</td>\n",
       "      <td>Coronavirus disease 2019 (COVID-19): current status and future perspectives</td>\n",
       "      <td>https://doi.org/10.1016/j.ijantimicag.2020.105951</td>\n",
       "      <td>however, there are no clinically approved vaccines or specific therapeutic drugs available for covid-19 0.09</td>\n",
       "      <td>0.085714</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-20</td>\n",
       "      <td>血液标本灭活处理对液相串联质谱法伏立康唑治疗药物监测的影响及其在COVID-19疫情期间的应用</td>\n",
       "      <td>https://doi.org/10.12122/j.issn.1673-4254.2020.03.08</td>\n",
       "      <td>conclusion: heat inactivation at 56 ℃ for 30 min combined with ethanol sample preparation only has limited effects to affect lc-ms-based voriconazole concentration measurement in whole blood samples collected in heparinized tubes, and can be used for therapeutic drug monitoring of voriconazole during the ongoing covid-19 pandemic 0.14</td>\n",
       "      <td>0.142553</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-01-29</td>\n",
       "      <td>Therapeutic Drugs Targeting 2019-nCoV Main Protease by High-Throughput Screening</td>\n",
       "      <td>https://doi.org/10.1101/2020.01.28.922922</td>\n",
       "      <td>therapeutic drugs targeting 2019-ncov main protease by high-throughput screening 0.11</td>\n",
       "      <td>0.105556</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "three drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-03-06</td>\n",
       "      <td>Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model</td>\n",
       "      <td>https://doi.org/10.1097/cm9.0000000000000797</td>\n",
       "      <td>three drugs, including cepharanthine (cep), selamectin, and mefloquine hydrochloride, exhibited complete inhibition of cytopathic effects in cell culture at 10 μmol/l 0.07</td>\n",
       "      <td>0.073810</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-21</td>\n",
       "      <td>Functional pangenome analysis suggests inhibition of the protein E as a readily available therapy for COVID-2019</td>\n",
       "      <td>https://doi.org/10.1101/2020.02.17.952895</td>\n",
       "      <td>however, three drugs approved for human use may inhibit sars-cov-1 and sars-cov-2 protein e, either acting upon the ion channel (amantadine and hexamethylene amiloride9,10) or the pbm (sb2035805), thereby potentially increasing the survival of the host, as already demonstrated for sars-cov-1in animal models 0.06</td>\n",
       "      <td>0.061628</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "unlicensed drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-03-27</td>\n",
       "      <td>Modelling SARS-CoV-2 Dynamics: Implications for Therapy</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.23.20040493</td>\n",
       "      <td>furthermore, we used our viral dynamics model to predict the effectiveness of unlicensed drugs that have different methods of action 0.08</td>\n",
       "      <td>0.075</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "viral drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020-06-30</td>\n",
       "      <td>Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses</td>\n",
       "      <td>https://doi.org/10.1016/j.onehlt.2020.100128</td>\n",
       "      <td>remdesivir (gs-5734™) is a broad-spectrum antiviral drug that is now being tested as a potential treatment for covid-19 in international, multi-site clinical trials 0.07</td>\n",
       "      <td>0.071739</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-21</td>\n",
       "      <td>Elucidating the differences in the molecular mechanism of receptor binding between 2019-nCoV and the SARS-CoV viruses using computational tools</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.21.053009</td>\n",
       "      <td>many biotechnology laboratories are rushing to develop therapeutic antibodies and antiviral drugs for treatment of this viral disease 0.08</td>\n",
       "      <td>0.077778</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-21</td>\n",
       "      <td>Human iPSC-Derived Cardiomyocytes are Susceptible to SARS-CoV-2 Infection</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.21.051912</td>\n",
       "      <td>these studies show that sars-cov-2 can infect hipsc-cms in vitro, establishing a model for elucidating the mechanisms of infection and potentially a cardiac-specific antiviral drug screening platform 0.07</td>\n",
       "      <td>0.068519</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-19</td>\n",
       "      <td>Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status</td>\n",
       "      <td>https://doi.org/10.1016/j.meegid.2020.104327</td>\n",
       "      <td>favilavir is an antiviral drug that is approved in japan for common influenza treatment and is now approved to treat symptoms of covid-19 in china 0.07</td>\n",
       "      <td>0.070000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-19</td>\n",
       "      <td>Déjà vu: Stimulating open drug discovery for SARS-CoV-2</td>\n",
       "      <td>https://doi.org/10.1016/j.drudis.2020.03.019</td>\n",
       "      <td>here, we propose, based on open antiviral drug discovery approaches for previous outbreaks, that there could still be gaps in our approach to drug discovery 0.09</td>\n",
       "      <td>0.090000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-15</td>\n",
       "      <td>TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS-CoV-2 in human airway epithelial cells and provide promising drug targets</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.15.042085</td>\n",
       "      <td>currently, there is no approved antiviral drug for treating covid-19 patients and there is an urgent need for specific antiviral therapies and vaccines 0.07</td>\n",
       "      <td>0.071739</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-15</td>\n",
       "      <td>Epidemiological investigation and intergenerational clinical characteristics of 24 COVID-19 patients associated with supermarket cluster</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.11.20058891</td>\n",
       "      <td>treatment: antiviral drug (100%), chinese medicine (100%), common oxygen therapy (45 0.1</td>\n",
       "      <td>0.095455</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-14</td>\n",
       "      <td>Calcium channel blocker amlodipine besylate is associated with reduced case fatality rate of COVID-19 patients with hypertension</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.08.20047134</td>\n",
       "      <td>development of effective anti-viral drug is in urgent need to treat covid-19 patients 0.09</td>\n",
       "      <td>0.088462</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-14</td>\n",
       "      <td>Efficacy of remdesivir versus placebo for the treatment of COVID-19: A protocol for systematic review and meta-analysis of randomized controlled trials</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.09.20059196</td>\n",
       "      <td>remdesivir, a nucleotide-analogue antiviral drug developed for ebola, is determined to prevent and stop infections with covid-19, while results are yet controversial 0.07</td>\n",
       "      <td>0.072727</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-14</td>\n",
       "      <td>Dos terapias conocidas podrían ser efectivas como adyuvantes en el paciente crítico infectado por COVID-19</td>\n",
       "      <td>https://doi.org/10.1016/j.redar.2020.03.004</td>\n",
       "      <td>unfortunately, there is not yet a specific vaccine or effective antiviral drug for treating covid-19 0.08</td>\n",
       "      <td>0.083333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-14</td>\n",
       "      <td>Associations of clinical characteristics and antiviral drugs with viral RNA clearance in patients with COVID-19 in Guangzhou, China: a retrospective cohort study</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.09.20058941</td>\n",
       "      <td>conclusion: in patients with covid-19, isolation for a minimum of 21 days after onset of illness may be warranted, while the use of antiviral drugs does not enhance viral rna clearance 0.07 associations of clinical characteristics and antiviral drugs with viral rna clearance in patients with covid-19 in guangzhou, china: a retrospective cohort study 0.07</td>\n",
       "      <td>0.072727</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-11</td>\n",
       "      <td>Analysis of the mutation dynamics of SARS-CoV-2 reveals the spread history and emergence of RBD mutant with lower ACE2 binding affinity</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.09.034942</td>\n",
       "      <td>the spike (s) protein encoding gene of sars-cov-2 is found relatively more conserved than other protein-encoding genes, which is a good indication for the ongoing antiviral drug and vaccine development 0.07</td>\n",
       "      <td>0.066667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-09</td>\n",
       "      <td>The IMPDH inhibitor merimepodib suppresses SARS-CoV-2 replication in vitro</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.07.028589</td>\n",
       "      <td>the impdh inhibitor merimepodib (mmpd) is an investigational antiviral drug that acts as a noncompetitive inhibitor of impdh 0.08</td>\n",
       "      <td>0.077778</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-09</td>\n",
       "      <td>Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.08.032763</td>\n",
       "      <td>the replication of sars-cov-2 requires the viral rna-dependent rna polymerase (rdrp), a direct target of the antiviral drug, remdesivir 0.08</td>\n",
       "      <td>0.076316</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-04-07</td>\n",
       "      <td>Repurposing Therapeutics for COVID-19: Rapid Prediction of Commercially available drugs through Machine Learning and Docking</td>\n",
       "      <td>https://doi.org/10.1101/2020.04.05.20054254</td>\n",
       "      <td>among all, we suggest that the antiretroviral drug saquinavir (drugbank id db01232) would probably be one of the most effective drugs based on the selected criterions 0.07</td>\n",
       "      <td>0.069231</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-31</td>\n",
       "      <td>Computational Design of Peptides to Block Binding of the SARS-CoV-2 Spike Protein to Human ACE2</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.28.013607</td>\n",
       "      <td>making the problem worse, there is no specific antiviral drug that can be used to treat covid-19 to date 0.08  therefore, molecules that can block sars-cov-2 from binding to hace2 may potentially prevent the virus from entering human cells and serve as an effective antiviral drug 0.07</td>\n",
       "      <td>0.076316</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-28</td>\n",
       "      <td>Structure-Based Design, Synthesis and Biological Evaluation of Peptidomimetic Aldehydes as a Novel Series of Antiviral Drug Candidates Targeting the SARS-CoV-2 Main Protease</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.25.996348</td>\n",
       "      <td>structure-based design, synthesis and biological evaluation of peptidomimetic aldehydes as a novel series of antiviral drug candidates targeting the sars-cov-2 main protease 0.07</td>\n",
       "      <td>0.072727</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-27</td>\n",
       "      <td>Codon usage and evolutionary rates of the 2019-nCoV genes</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.25.006569</td>\n",
       "      <td>conversely, genes encoding nucleocapsid (n), viral replicase and spike proteins are important targets for the development of vaccines and antiviral drugs, tend to evolve faster as compared to other ones 0.07</td>\n",
       "      <td>0.066667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-20</td>\n",
       "      <td>Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.20.999730</td>\n",
       "      <td>drug repositioning represents the only feasible option to address this global challenge and a panel of fifty fda-approved drugs that have been pre-selected by an assay of sars-cov was screened to identify potential antiviral drug candidates against sars-cov-2 infection 0.08 identification of antiviral drug candidates against sars-cov-2 from fda-approved drugs 0.1</td>\n",
       "      <td>0.100000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-17</td>\n",
       "      <td>Structure of RNA-dependent RNA polymerase from 2019-nCoV, a major antiviral drug target</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.16.993386</td>\n",
       "      <td>the rna-dependent rna polymerase (rdrp, also named nsp12), which catalyzes the synthesis of viral rna, is a key component of coronaviral replication/transcription machinery and appears to be a primary target for the antiviral drug, remdesivir 0.06 structure of rna-dependent rna polymerase from 2019-ncov, a major antiviral drug target 0.09</td>\n",
       "      <td>0.091667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-16</td>\n",
       "      <td>COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses</td>\n",
       "      <td>https://doi.org/10.1016/j.jare.2020.03.005</td>\n",
       "      <td>there is no clinically approved antiviral drug or vaccine available to be used against covid-19 0.08</td>\n",
       "      <td>0.083333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-16</td>\n",
       "      <td>Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2</td>\n",
       "      <td>https://doi.org/10.1038/s41421-020-0153-3</td>\n",
       "      <td>in this study, we present an integrative, antiviral drug repurposing methodology implementing a systems pharmacology-based network medicine platform, quantifying the interplay between the hcov–host interactome and drug targets in the human protein–protein interaction network 0.08</td>\n",
       "      <td>0.079412</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-08</td>\n",
       "      <td>Substrate specificity profiling of SARS-CoV-2 Mpro protease provides basis for anti-COVID-19 drug design</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.07.981928</td>\n",
       "      <td>the sars-cov-2 mpro protease constitutes one of the most attractive antiviral drug targets 0.09</td>\n",
       "      <td>0.088462</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-08</td>\n",
       "      <td>AI-aided design of novel targeted covalent inhibitors against SARS-CoV-2</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.03.972133</td>\n",
       "      <td>as a key enzyme in the life-cycle of coronavirus, the 3c-like main protease (3clpro or mpro) is the most attractive for antiviral drug design 0.07</td>\n",
       "      <td>0.070833</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-03-07</td>\n",
       "      <td>Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites</td>\n",
       "      <td>https://doi.org/10.1101/2020.03.06.977876</td>\n",
       "      <td>viral nucleocapsid protein is a potential antiviral drug target, serving multiple critical functions during the viral life cycle 0.27</td>\n",
       "      <td>0.266667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>2020-02-05</td>\n",
       "      <td>Network-based Drug Repurposing for Human Coronavirus</td>\n",
       "      <td>https://doi.org/10.1101/2020.02.03.20020263</td>\n",
       "      <td>in this study, we present an integrative, antiviral drug repurposing methodology implementing a systems pharmacology-based network medicine platform, quantifying the interplay between the hcov-host interactome and drug targets in the human protein-protein interaction network 0.08</td>\n",
       "      <td>0.079412</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "virus drug\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>date</th>\n",
       "      <th>study</th>\n",
       "      <th>link</th>\n",
       "      <th>excerpt</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>2020</td>\n",
       "      <td>Pharmacotherapeutics for the New Coronavirus Pneumonia</td>\n",
       "      <td>https://doi.org/10.3760/cma.j.issn.1001-0939.2020.0012</td>\n",
       "      <td>combination of ribavirin and interferon-α is recommended by the 5(th) edition national health commission's regimen (revised edition) because of the effect on mers (middle east respiratory syndrome), and the effectiveness of lopinavir/ritonavir and remdisivir needs to be confirmed by randomized controlled trial (rct), given the situation of no specific antivirus drug on ncp is unavailable 0.06</td>\n",
       "      <td>0.059091</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# custom sentence score\n",
    "def score_sentence_prob(search,sentence,focus):\n",
    "    final_score=0\n",
    "    keywords=search.split()\n",
    "    sent_parts=sentence.split()\n",
    "    word_match=0\n",
    "    missing=0\n",
    "    for word in keywords:\n",
    "        word_count=sent_parts.count(word)\n",
    "        word_match=word_match+word_count\n",
    "        if word_count==0:\n",
    "            missing=missing+1\n",
    "    percent = 1-(missing/len(keywords))\n",
    "    final_score=abs((word_match/len(sent_parts)) * percent)\n",
    "    if missing==0:\n",
    "        final_score=final_score+.05\n",
    "    if focus in sentence:\n",
    "        final_score=final_score+.05\n",
    "    return final_score\n",
    "\n",
    "def score_docs(df,focus,search):\n",
    "    df_results = pd.DataFrame(columns=['date','study','link','excerpt','score'])\n",
    "    df1=df[functools.reduce(lambda a, b: a&b, (df['abstract'].str.contains(s) for s in focus))]\n",
    "    master_text=''\n",
    "    for index, row in df1.iterrows():\n",
    "        pub_sentence=''\n",
    "        sentences=row['abstract'].split('.')\n",
    "        hi_score=0\n",
    "        for sentence in sentences:\n",
    "            if len(sentence)>75 and search in sentence:\n",
    "                rel_score=score_sentence_prob(search,sentence,focus)\n",
    "                #rel_score=score_sentence(search,sentence)\n",
    "                if rel_score>.05:\n",
    "                    #print (sentence,rel_score)\n",
    "                    pub_sentence=pub_sentence+' '+sentence+' '+str(round(rel_score,2))\n",
    "                    if rel_score>hi_score:\n",
    "                        hi_score=rel_score\n",
    "                    master_text=master_text+' '+pub_sentence\n",
    "        if pub_sentence!='':\n",
    "            #print (row['abstract'])\n",
    "            #print ('------------------')\n",
    "            link=row['doi']\n",
    "            linka='https://doi.org/'+link\n",
    "            to_append = [row['publish_time'],row['title'],linka,pub_sentence,hi_score]\n",
    "            df_length = len(df_results)\n",
    "            df_results.loc[df_length] = to_append\n",
    "    df_results=df_results.sort_values(by=['date'], ascending=False)\n",
    "\n",
    "    return df_results\n",
    "for term in term_list:\n",
    "    if 'drug' in term and any(map(str.isdigit, term))==False and ')' not in term:\n",
    "        df_results=score_docs(df,focus_term,term)\n",
    "        if df_results.empty==False:\n",
    "            print (term)\n",
    "            df_table_show=HTML(df_results.to_html(escape=False,index=False))\n",
    "            display(df_table_show)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "environment": {
   "name": "common-cpu.m47",
   "type": "gcloud",
   "uri": "gcr.io/deeplearning-platform-release/base-cpu:m47"
  },
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
